| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.614 | 0.002 | 0.614 | CC chemokine receptor 2B antagonist | 0.356 0.003 DBMET02770 | ||
| 0.581 | 0.01 | 0.619 | GABA C receptor rho-3 antagonist | 0.476 0.033 DBMET02759 0.428 0.05 DBMET02768 0.619 0.005 DBMET02770 0.403 0.06 DBMET02760 0.428 0.05 DBMET02769 0.614 0.006 DBMET02761 0.518 0.021 DBMET02762 0.375 0.073 DBMET02765 0.263 0.143 DBMET02767 | DBMET02770 | |
| 0.398 | 0.001 | 0.398 | Alpha 2d adrenoreceptor agonist | 0.021 0.016 DBMET02770 | ||
| 0.374 | 0.003 | 0.374 | CYP2A6 inhibitor | 0.071 0.058 DBMET02759 0.109 0.032 DBMET02768 0.071 0.058 DBMET02770 0.117 0.028 DBMET02769 0.203 0.007 DBMET02761 0.141 0.019 DBMET02762 | ||
| 0.373 | 0.051 | 0.677 | 5 Hydroxytryptamine release stimulant | 0.223 0.104 DBMET02759 0.167 0.157 DBMET02768 0.247 0.09 DBMET02770 0.184 0.136 DBMET02769 0.677 0.008 DBMET02761 0.521 0.024 DBMET02762 0.277 0.078 DBMET02765 0.184 0.136 DBMET02767 | DBMET02761 | |
| 0.323 | 0.005 | 0.323 | Antibacterial (Helicobacter pylori) | 0.107 0.105 DBMET02759 0.14 0.056 DBMET02768 0.189 0.025 DBMET02770 0.161 0.038 DBMET02769 0.156 0.042 DBMET02761 0.264 0.01 DBMET02762 0.109 0.101 DBMET02765 | ||
| 0.408 | 0.094 | 0.53 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.432 0.074 DBMET02759 0.3 0.213 DBMET02768 0.407 0.094 DBMET02770 0.29 0.226 DBMET02760 0.3 0.213 DBMET02769 0.53 0.022 DBMET02761 0.495 0.036 DBMET02762 0.423 0.082 DBMET02765 0.342 0.159 DBMET02767 | DBMET02761 | |
| 0.325 | 0.036 | 0.338 | DNA synthesis inhibitor | 0.338 0.033 DBMET02759 0.243 0.072 DBMET02768 0.293 0.046 DBMET02770 0.307 0.041 DBMET02760 0.256 0.063 DBMET02769 0.333 0.034 DBMET02761 0.306 0.042 DBMET02762 0.273 0.054 DBMET02765 0.217 0.098 DBMET02767 | DBMET02759 | |
| 0.346 | 0.075 | 0.346 | Thyroid hormone antagonist | 0.239 0.131 DBMET02759 0.276 0.107 DBMET02770 | ||
| 0.304 | 0.037 | 0.501 | Peroxidase inhibitor | 0.311 0.035 DBMET02759 0.271 0.043 DBMET02768 0.178 0.066 DBMET02770 0.312 0.035 DBMET02760 0.315 0.034 DBMET02769 0.501 0.009 DBMET02761 0.5 0.009 DBMET02762 0.352 0.028 DBMET02765 0.235 0.051 DBMET02767 | DBMET02761 | |
| 0.257 | 0.009 | 0.257 | Raf kinase inhibitor | 0.081 0.044 DBMET02768 0.115 0.027 DBMET02769 | ||
| 0.253 | 0.005 | 0.253 | Thioredoxin inhibitor | 0.104 0.044 DBMET02768 0.121 0.03 DBMET02769 0.194 0.009 DBMET02761 | ||
| 0.247 | 0.002 | 0.247 | Dopamine beta hydroxylase inhibitor | 0.133 0.003 DBMET02759 0.072 0.007 DBMET02768 0.095 0.004 DBMET02770 0.109 0.004 DBMET02760 0.073 0.007 DBMET02769 0.059 0.016 DBMET02761 0.083 0.005 DBMET02762 0.06 0.015 DBMET02765 0.046 0.041 DBMET02767 | ||
| 0.253 | 0.012 | 0.253 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | 0.087 0.065 DBMET02768 0.121 0.039 DBMET02769 | ||
| 0.276 | 0.038 | 0.39 | RNA-directed DNA polymerase inhibitor | 0.39 0.019 DBMET02759 0.217 0.077 DBMET02768 0.358 0.023 DBMET02770 0.272 0.039 DBMET02760 0.23 0.064 DBMET02769 0.296 0.032 DBMET02761 0.259 0.045 DBMET02762 0.223 0.07 DBMET02765 0.182 0.129 DBMET02767 | DBMET02759 | |
| 0.288 | 0.052 | 0.452 | 5 Hydroxytryptamine uptake stimulant | 0.275 0.06 DBMET02759 0.206 0.14 DBMET02768 0.282 0.055 DBMET02770 0.232 0.101 DBMET02760 0.223 0.113 DBMET02769 0.452 0.007 DBMET02761 0.325 0.034 DBMET02762 0.223 0.113 DBMET02765 0.188 0.176 DBMET02767 | DBMET02761 | |
| 0.334 | 0.105 | 0.334 | MAP kinase kinase 6 inhibitor | 0.316 0.12 DBMET02770 | ||
| 0.242 | 0.013 | 0.273 | GABA C receptor rho-2 antagonist | 0.196 0.031 DBMET02759 0.15 0.073 DBMET02768 0.26 0.01 DBMET02770 0.158 0.064 DBMET02760 0.15 0.073 DBMET02769 0.273 0.008 DBMET02761 0.254 0.011 DBMET02762 0.187 0.037 DBMET02765 0.142 0.085 DBMET02767 | DBMET02761 | |
| 0.23 | 0.008 | 0.23 | Gastric antisecretory | 0.102 0.063 DBMET02768 0.135 0.034 DBMET02769 0.103 0.062 DBMET02761 0.158 0.023 DBMET02762 0.133 0.035 DBMET02765 0.091 0.077 DBMET02767 | ||
| 0.309 | 0.097 | 0.464 | Thioredoxin glutathione reductase inhibitor | 0.464 0.037 DBMET02770 0.268 0.123 DBMET02762 | DBMET02770 | |
| 0.224 | 0.014 | 0.224 | Chemokine receptor antagonist | |||
| 0.261 | 0.058 | 0.413 | Tyrosine 3 hydroxylase inhibitor | 0.248 0.07 DBMET02759 0.193 0.149 DBMET02768 0.28 0.044 DBMET02770 0.238 0.081 DBMET02760 0.205 0.127 DBMET02769 0.413 0.007 DBMET02761 0.308 0.03 DBMET02762 0.24 0.079 DBMET02765 0.205 0.127 DBMET02767 | DBMET02761 | |
| 0.285 | 0.083 | 0.285 | Immunostimulant | 0.166 0.142 DBMET02759 0.212 0.113 DBMET02770 0.24 0.1 DBMET02761 0.186 0.129 DBMET02762 0.235 0.103 DBMET02765 0.156 0.149 DBMET02767 | ||
| 0.315 | 0.124 | 0.475 | Antibacterial | 0.28 0.15 DBMET02759 0.335 0.111 DBMET02770 0.235 0.191 DBMET02769 0.393 0.08 DBMET02761 0.475 0.048 DBMET02762 0.422 0.067 DBMET02765 0.458 0.054 DBMET02767 | DBMET02762 | |
| 0.204 | 0.02 | 0.445 | GABA C receptor agonist | 0.133 0.042 DBMET02759 0.127 0.045 DBMET02768 0.195 0.021 DBMET02770 0.149 0.034 DBMET02760 0.127 0.045 DBMET02769 0.445 0.004 DBMET02761 0.315 0.008 DBMET02762 0.186 0.023 DBMET02765 0.125 0.046 DBMET02767 | DBMET02761 | |
| 0.219 | 0.037 | 0.274 | 5 Hydroxytryptamine 3E antagonist | 0.19 0.081 DBMET02759 0.169 0.139 DBMET02768 0.192 0.077 DBMET02770 0.184 0.095 DBMET02769 0.274 0.009 DBMET02761 0.272 0.009 DBMET02762 0.218 0.038 DBMET02765 0.204 0.056 DBMET02767 | DBMET02761 | |
| 0.201 | 0.022 | 0.396 | Ferrochelatase inhibitor | 0.186 0.026 DBMET02759 0.121 0.053 DBMET02768 0.277 0.01 DBMET02770 0.155 0.036 DBMET02760 0.121 0.053 DBMET02769 0.396 0.004 DBMET02761 0.241 0.015 DBMET02762 0.138 0.043 DBMET02765 | DBMET02761 | |
| 0.208 | 0.032 | 0.208 | NADPH oxidase inhibitor | 0.172 0.044 DBMET02770 0.115 0.09 DBMET02761 | ||
| 0.254 | 0.081 | 0.685 | Aldehyde oxidase inhibitor | 0.386 0.049 DBMET02759 0.221 0.094 DBMET02770 0.361 0.053 DBMET02760 0.685 0.009 DBMET02761 0.334 0.058 DBMET02762 0.296 0.067 DBMET02765 0.202 0.104 DBMET02767 | DBMET02761 | |
| 0.202 | 0.035 | 0.202 | Toll-Like receptor 9 antagonist | 0.113 0.094 DBMET02768 0.141 0.069 DBMET02769 0.11 0.098 DBMET02761 0.124 0.082 DBMET02762 | ||
| 0.274 | 0.108 | 0.307 | Antithrombotic | 0.206 0.17 DBMET02770 0.217 0.157 DBMET02769 0.307 0.084 DBMET02761 0.247 0.129 DBMET02765 | DBMET02761 | |
| 0.317 | 0.151 | 0.472 | Alpha-glucosidase inhibitor | 0.274 0.174 DBMET02759 0.472 0.089 DBMET02770 | DBMET02770 | |
| 0.243 | 0.079 | 0.496 | Superoxide dismutase inhibitor | 0.231 0.088 DBMET02759 0.268 0.064 DBMET02768 0.186 0.134 DBMET02770 0.203 0.114 DBMET02760 0.297 0.052 DBMET02769 0.496 0.013 DBMET02761 0.353 0.036 DBMET02762 0.467 0.016 DBMET02765 0.356 0.035 DBMET02767 | DBMET02761 | |
| 0.197 | 0.035 | 0.647 | Alpha-N-acetylglucosaminidase inhibitor | 0.207 0.032 DBMET02759 0.142 0.06 DBMET02768 0.229 0.027 DBMET02770 0.217 0.03 DBMET02760 0.142 0.06 DBMET02769 0.647 0.003 DBMET02761 0.307 0.015 DBMET02762 0.297 0.016 DBMET02765 0.204 0.033 DBMET02767 | DBMET02761 | |
| 0.177 | 0.015 | 0.258 | Alcohol dehydrogenase inhibitor | 0.258 0.007 DBMET02759 0.254 0.007 DBMET02768 0.18 0.015 DBMET02760 0.198 0.013 DBMET02769 0.192 0.013 DBMET02761 0.161 0.018 DBMET02762 0.133 0.027 DBMET02765 | DBMET02759 | |
| 0.206 | 0.045 | 0.61 | Cytidine deaminase inhibitor | 0.61 0.004 DBMET02759 0.246 0.03 DBMET02770 0.586 0.004 DBMET02760 0.239 0.032 DBMET02761 | DBMET02759 | |
| 0.193 | 0.033 | 0.685 | Histone deacetylase SIRT1 inhibitor | 0.257 0.016 DBMET02770 0.685 0.002 DBMET02762 0.27 0.013 DBMET02765 0.195 0.032 DBMET02767 | DBMET02762 | |
| 0.236 | 0.085 | 0.329 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.249 0.066 DBMET02770 0.301 0.024 DBMET02762 0.329 0.015 DBMET02765 0.27 0.044 DBMET02767 | DBMET02765 | |
| 0.155 | 0.006 | 0.155 | Alpha 2 adrenoreceptor agonist | 0.068 0.034 DBMET02770 0.068 0.033 DBMET02762 | ||
| 0.164 | 0.016 | 0.239 | GABA C receptor rho-1 antagonist | 0.123 0.037 DBMET02759 0.094 0.071 DBMET02768 0.181 0.012 DBMET02770 0.101 0.061 DBMET02760 0.094 0.071 DBMET02769 0.213 0.006 DBMET02761 0.239 0.005 DBMET02762 0.14 0.026 DBMET02765 0.099 0.064 DBMET02767 | DBMET02762 | |
| 0.184 | 0.037 | 0.233 | Cell wall synthesis inhibitor | 0.115 0.108 DBMET02759 0.207 0.027 DBMET02768 0.181 0.039 DBMET02770 0.142 0.073 DBMET02760 0.23 0.02 DBMET02769 0.189 0.035 DBMET02761 0.206 0.028 DBMET02762 0.233 0.019 DBMET02765 0.176 0.042 DBMET02767 | DBMET02765 | |
| 0.3 | 0.154 | 0.431 | Transcription factor inhibitor | 0.431 0.098 DBMET02759 0.368 0.123 DBMET02770 0.29 0.16 DBMET02760 0.285 0.163 DBMET02761 0.299 0.155 DBMET02762 | DBMET02759 | |
| 0.21 | 0.065 | 0.21 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | |||
| 0.311 | 0.169 | 0.311 | MAP kinase 1 inhibitor | |||
| 0.162 | 0.021 | 0.191 | Ca2+-transporting ATPase inhibitor | 0.157 0.029 DBMET02759 0.155 0.033 DBMET02768 0.147 0.05 DBMET02770 0.154 0.034 DBMET02760 0.155 0.033 DBMET02769 0.191 0.004 DBMET02761 0.148 0.048 DBMET02762 0.143 0.063 DBMET02765 0.13 0.118 DBMET02767 | DBMET02761 | |
| 0.211 | 0.074 | 0.211 | Platelet aggregation inhibitor | |||
| 0.243 | 0.107 | 0.475 | Streptokinase A inhibitor | 0.416 0.043 DBMET02759 0.475 0.032 DBMET02770 0.253 0.101 DBMET02760 0.358 0.059 DBMET02762 | DBMET02770 | |
| 0.185 | 0.05 | 0.317 | Amylase inhibitor | 0.285 0.02 DBMET02759 0.317 0.016 DBMET02770 0.232 0.034 DBMET02760 0.218 0.038 DBMET02761 0.104 0.093 DBMET02762 | DBMET02770 | |
| 0.264 | 0.131 | 0.39 | Calcium channel activator | 0.232 0.169 DBMET02759 0.276 0.118 DBMET02768 0.252 0.145 DBMET02770 0.295 0.096 DBMET02769 0.39 0.029 DBMET02761 0.297 0.094 DBMET02762 0.332 0.063 DBMET02765 0.269 0.125 DBMET02767 | DBMET02761 | |
| 0.185 | 0.052 | 0.204 | ATPase inhibitor | 0.177 0.062 DBMET02770 0.204 0.034 DBMET02761 | DBMET02761 | |
| 0.147 | 0.017 | 0.147 | Alpha adrenoreceptor agonist | 0.12 0.022 DBMET02770 | ||
| 0.199 | 0.07 | 0.222 | Histone acetyltransferase inhibitor | 0.222 0.042 DBMET02761 0.192 0.081 DBMET02762 | DBMET02761 | |
| 0.156 | 0.027 | 0.259 | GABA C receptor antagonist | 0.121 0.052 DBMET02759 0.144 0.033 DBMET02768 0.178 0.018 DBMET02770 0.109 0.065 DBMET02760 0.163 0.024 DBMET02769 0.252 0.006 DBMET02761 0.259 0.005 DBMET02762 0.229 0.008 DBMET02765 0.183 0.017 DBMET02767 | DBMET02762 | |
| 0.133 | 0.005 | 0.133 | H+/K+-transporting ATPase inhibitor | 0.059 0.026 DBMET02768 0.079 0.013 DBMET02769 | ||
| 0.16 | 0.036 | 0.722 | Histone deacetylase class III inhibitor | 0.261 0.009 DBMET02770 0.722 0.003 DBMET02762 0.179 0.027 DBMET02765 0.107 0.083 DBMET02767 | DBMET02762 | |
| 0.223 | 0.1 | 0.458 | Cardiotonic | 0.458 0.02 DBMET02761 0.281 0.065 DBMET02762 0.256 0.079 DBMET02765 | DBMET02761 | |
| 0.135 | 0.012 | 0.135 | Thioredoxin reductase inhibitor | |||
| 0.136 | 0.014 | 0.136 | Myeloperoxidase inhibitor | 0.101 0.034 DBMET02770 0.094 0.043 DBMET02761 0.117 0.022 DBMET02762 | ||
| 0.233 | 0.114 | 0.342 | Insulysin inhibitor | 0.289 0.065 DBMET02759 0.198 0.16 DBMET02768 0.27 0.079 DBMET02770 0.238 0.108 DBMET02760 0.215 0.135 DBMET02769 0.342 0.037 DBMET02761 0.332 0.041 DBMET02762 0.33 0.042 DBMET02765 0.284 0.069 DBMET02767 | DBMET02761 | |
| 0.199 | 0.082 | 0.458 | Pyruvate kinase inhibitor | 0.458 0.013 DBMET02759 0.153 0.112 DBMET02768 0.188 0.088 DBMET02770 0.37 0.027 DBMET02760 0.176 0.096 DBMET02769 0.272 0.055 DBMET02761 | DBMET02759 | |
| 0.14 | 0.023 | 0.164 | Acetylcholine release stimulant | 0.111 0.065 DBMET02768 0.164 0.01 DBMET02770 0.119 0.049 DBMET02769 0.157 0.013 DBMET02761 0.102 0.082 DBMET02762 | DBMET02770 | |
| 0.225 | 0.111 | 0.371 | Gastrin inhibitor | 0.222 0.116 DBMET02768 0.249 0.08 DBMET02770 0.288 0.042 DBMET02769 0.306 0.029 DBMET02761 0.261 0.067 DBMET02762 0.3 0.033 DBMET02765 0.371 0.007 DBMET02767 | DBMET02767 | |
| 0.192 | 0.079 | 0.401 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.401 0.008 DBMET02759 0.189 0.082 DBMET02770 0.33 0.016 DBMET02760 0.317 0.019 DBMET02761 0.219 0.058 DBMET02762 | DBMET02759 | |
| 0.127 | 0.013 | 0.491 | Alcohol oxidase inhibitor | 0.048 0.047 DBMET02759 0.059 0.036 DBMET02768 0.061 0.035 DBMET02770 0.053 0.042 DBMET02760 0.059 0.036 DBMET02769 0.491 0.004 DBMET02761 0.444 0.004 DBMET02762 0.054 0.041 DBMET02765 | DBMET02761 | |
| 0.187 | 0.076 | 0.247 | DNA methyltransferase I inhibitor | 0.167 0.089 DBMET02759 0.196 0.071 DBMET02770 0.247 0.048 DBMET02761 | DBMET02761 | |
| 0.3 | 0.193 | 0.727 | Caspase 9 stimulant | 0.344 0.151 DBMET02759 0.279 0.218 DBMET02770 0.303 0.19 DBMET02760 0.727 0.021 DBMET02761 0.364 0.135 DBMET02762 | DBMET02761 | |
| 0.121 | 0.023 | 0.121 | Alpha 2d adrenoreceptor antagonist | |||
| 0.114 | 0.016 | 0.114 | Sirtuin 1 inhibitor | 0.113 0.017 DBMET02770 0.103 0.021 DBMET02762 | ||
| 0.129 | 0.032 | 0.167 | Prolactin inhibitor | 0.086 0.073 DBMET02759 0.117 0.04 DBMET02770 0.082 0.078 DBMET02769 0.167 0.016 DBMET02761 0.104 0.051 DBMET02762 | DBMET02761 | |
| 0.148 | 0.051 | 0.163 | Heat shock protein 70 antagonist | 0.156 0.034 DBMET02759 0.13 0.122 DBMET02768 0.146 0.055 DBMET02770 0.132 0.108 DBMET02760 0.135 0.097 DBMET02769 0.155 0.036 DBMET02761 0.163 0.025 DBMET02762 0.134 0.102 DBMET02765 | DBMET02762 | |
| 0.114 | 0.019 | 0.726 | Histone deacetylase SIRT2 inhibitor | 0.22 0.005 DBMET02770 0.726 0.002 DBMET02762 0.118 0.016 DBMET02765 | DBMET02762 | |
| 0.206 | 0.11 | 0.337 | DNA damaging | 0.205 0.111 DBMET02761 0.337 0.045 DBMET02762 0.238 0.088 DBMET02765 | DBMET02762 | |
| 0.212 | 0.117 | 0.251 | 5 Hydroxytryptamine 1E antagonist | 0.185 0.149 DBMET02770 0.251 0.074 DBMET02761 0.218 0.11 DBMET02762 | DBMET02761 | |
| 0.191 | 0.1 | 0.324 | Cyclic AMP phosphodiesterase inhibitor | 0.259 0.059 DBMET02759 0.258 0.06 DBMET02770 0.324 0.033 DBMET02761 0.19 0.102 DBMET02762 | DBMET02761 | |
| 0.18 | 0.093 | 0.233 | DNA methylase inhibitor | 0.163 0.106 DBMET02759 0.183 0.091 DBMET02770 0.233 0.058 DBMET02761 | DBMET02761 | |
| 0.124 | 0.038 | 0.237 | Creatine kinase inhibitor | 0.099 0.061 DBMET02759 0.156 0.022 DBMET02768 0.097 0.063 DBMET02770 0.103 0.056 DBMET02760 0.173 0.016 DBMET02769 0.237 0.006 DBMET02761 0.115 0.045 DBMET02762 0.13 0.034 DBMET02765 0.101 0.058 DBMET02767 | DBMET02761 | |
| 0.176 | 0.09 | 0.437 | Anesthetic general | 0.27 0.042 DBMET02770 0.204 0.072 DBMET02760 0.437 0.012 DBMET02761 0.237 0.056 DBMET02762 0.165 0.099 DBMET02765 | DBMET02761 | |
| 0.119 | 0.036 | 0.123 | MAP kinase kinase 1 inhibitor | 0.109 0.046 DBMET02768 0.123 0.032 DBMET02769 0.095 0.063 DBMET02761 | DBMET02769 | |
| 0.129 | 0.049 | 0.185 | 5 Hydroxytryptamine 3A agonist | 0.096 0.081 DBMET02759 0.145 0.038 DBMET02770 0.185 0.02 DBMET02761 0.121 0.055 DBMET02762 0.098 0.078 DBMET02765 | DBMET02761 | |
| 0.189 | 0.109 | 0.297 | Nitric-oxide synthase stimulant | 0.183 0.122 DBMET02770 0.297 0.012 DBMET02761 0.224 0.055 DBMET02762 0.186 0.116 DBMET02765 | DBMET02761 | |
| 0.181 | 0.102 | 0.181 | EphB2 antagonist | |||
| 0.082 | 0.005 | 0.082 | Alpha 1d adrenoreceptor agonist | 0.044 0.021 DBMET02768 0.05 0.016 DBMET02769 0.063 0.01 DBMET02761 0.046 0.019 DBMET02762 | ||
| 0.113 | 0.035 | 0.213 | Histamine N-methyltransferase inhibitor | 0.112 0.036 DBMET02759 0.085 0.061 DBMET02770 0.115 0.033 DBMET02761 0.213 0.005 DBMET02762 0.158 0.011 DBMET02765 0.126 0.025 DBMET02767 | DBMET02762 | |
| 0.161 | 0.084 | 0.161 | Death-associated protein kinase 2 inhibitor | 0.16 0.084 DBMET02770 | ||
| 0.104 | 0.031 | 0.163 | Histamine H2 receptor antagonist | 0.163 0.008 DBMET02762 0.12 0.021 DBMET02765 0.092 0.043 DBMET02767 | DBMET02762 | |
| 0.1 | 0.029 | 0.124 | D-Ala-D-Ala ligase inhibitor | 0.083 0.061 DBMET02759 0.09 0.044 DBMET02770 0.082 0.061 DBMET02760 0.116 0.016 DBMET02761 0.124 0.012 DBMET02762 0.079 0.071 DBMET02765 | DBMET02762 | |
| 0.09 | 0.021 | 0.108 | Potassium channel (ATP-sensitive) blocker | 0.063 0.054 DBMET02768 0.078 0.03 DBMET02769 0.108 0.012 DBMET02762 0.089 0.021 DBMET02765 0.07 0.04 DBMET02767 | DBMET02762 | |
| 0.115 | 0.047 | 0.473 | UDP-glucose 4-epimerase inhibitor | 0.155 0.027 DBMET02759 0.107 0.053 DBMET02770 0.116 0.046 DBMET02760 0.473 0.003 DBMET02761 0.112 0.049 DBMET02762 0.102 0.058 DBMET02765 | DBMET02761 | |
| 0.12 | 0.052 | 0.169 | Protein kinase C gamma inhibitor | 0.127 0.047 DBMET02759 0.112 0.06 DBMET02770 0.169 0.023 DBMET02762 0.123 0.05 DBMET02765 | DBMET02762 | |
| 0.172 | 0.106 | 0.294 | Anticonvulsant | 0.294 0.042 DBMET02770 0.154 0.124 DBMET02761 | DBMET02770 | |
| 0.106 | 0.041 | 0.115 | Phosphodiesterase 6D inhibitor | 0.09 0.076 DBMET02759 0.094 0.064 DBMET02768 0.105 0.042 DBMET02769 0.115 0.03 DBMET02761 | DBMET02761 | |
| 0.114 | 0.049 | 0.4 | Adenylate kinase inhibitor | 0.237 0.011 DBMET02759 0.159 0.023 DBMET02768 0.109 0.054 DBMET02770 0.183 0.018 DBMET02760 0.179 0.018 DBMET02769 0.4 0.003 DBMET02761 0.179 0.018 DBMET02762 0.187 0.017 DBMET02765 0.152 0.025 DBMET02767 | DBMET02761 | |
| 0.102 | 0.039 | 0.205 | Glutamate release inhibitor | 0.095 0.05 DBMET02759 0.104 0.037 DBMET02770 0.182 0.005 DBMET02761 0.205 0.005 DBMET02762 0.121 0.021 DBMET02765 0.092 0.058 DBMET02767 | DBMET02762 | |
| 0.073 | 0.01 | 0.073 | Alpha 1b adrenoreceptor agonist | |||
| 0.178 | 0.115 | 0.299 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.202 0.099 DBMET02759 0.149 0.144 DBMET02760 0.299 0.065 DBMET02761 | DBMET02761 | |
| 0.252 | 0.19 | 0.367 | DNA directed DNA polymerase inhibitor | 0.246 0.194 DBMET02759 0.367 0.13 DBMET02770 | DBMET02770 | |
| 0.093 | 0.034 | 0.148 | HIV-1 reverse transcriptase inhibitor | 0.148 0.014 DBMET02759 0.083 0.04 DBMET02770 | DBMET02759 | |
| 0.065 | 0.007 | 0.065 | Nerve growth factor antagonist | 0.04 0.035 DBMET02768 0.057 0.012 DBMET02770 0.04 0.035 DBMET02769 0.051 0.016 DBMET02761 0.052 0.016 DBMET02762 | ||
| 0.068 | 0.011 | 0.122 | Histamine H2 receptor agonist | 0.064 0.013 DBMET02761 0.122 0.003 DBMET02762 0.097 0.004 DBMET02765 0.08 0.007 DBMET02767 | DBMET02762 | |
| 0.078 | 0.021 | 0.148 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.148 0.009 DBMET02759 0.055 0.041 DBMET02768 0.057 0.038 DBMET02770 0.109 0.013 DBMET02760 0.055 0.041 DBMET02769 0.146 0.009 DBMET02761 0.074 0.023 DBMET02762 0.05 0.049 DBMET02765 | DBMET02759 | |
| 0.115 | 0.06 | 0.115 | EphA2 antagonist | |||
| 0.065 | 0.01 | 0.065 | Geranyltranstransferase inhibitor | 0.047 0.027 DBMET02768 0.048 0.025 DBMET02769 0.063 0.011 DBMET02761 0.042 0.034 DBMET02762 | ||
| 0.062 | 0.007 | 0.062 | Histamine H1 receptor agonist | 0.043 0.031 DBMET02768 0.043 0.031 DBMET02769 0.053 0.014 DBMET02761 0.062 0.007 DBMET02762 0.054 0.014 DBMET02765 0.043 0.032 DBMET02767 | ||
| 0.079 | 0.026 | 0.102 | TRPA1 antagonist | 0.074 0.029 DBMET02770 0.102 0.017 DBMET02761 | DBMET02761 | |
| 0.128 | 0.074 | 0.128 | Toll-Like receptor antagonist | |||
| 0.092 | 0.04 | 0.724 | Porphobilinogen synthase inhibitor | 0.099 0.036 DBMET02759 0.107 0.033 DBMET02768 0.065 0.061 DBMET02770 0.112 0.031 DBMET02760 0.137 0.023 DBMET02769 0.724 0.002 DBMET02761 0.123 0.027 DBMET02762 0.101 0.036 DBMET02765 0.071 0.055 DBMET02767 | DBMET02761 | |
| 0.071 | 0.019 | 0.149 | Histamine agonist | 0.149 0.005 DBMET02762 0.084 0.013 DBMET02765 0.054 0.035 DBMET02767 | DBMET02762 | |
| 0.091 | 0.041 | 0.091 | CC chemokine receptor antagonist | |||
| 0.087 | 0.038 | 0.336 | Histidine decarboxylase inhibitor | 0.077 0.045 DBMET02759 0.073 0.048 DBMET02760 0.336 0.005 DBMET02761 0.077 0.045 DBMET02762 0.071 0.05 DBMET02765 | DBMET02761 | |
| 0.127 | 0.078 | 0.19 | Alkaline phosphatase inhibitor | 0.19 0.037 DBMET02770 0.118 0.088 DBMET02761 | DBMET02770 | |
| 0.05 | 0.005 | 0.05 | Thymidine phosphorylase inhibitor | 0.034 0.009 DBMET02770 0.027 0.016 DBMET02761 0.036 0.008 DBMET02762 | ||
| 0.054 | 0.009 | 0.076 | Purinergic P2Y2 antagonist | 0.068 0.006 DBMET02768 0.076 0.005 DBMET02769 0.062 0.007 DBMET02765 0.051 0.01 DBMET02767 | DBMET02769 | |
| 0.071 | 0.027 | 0.073 | Cyclin D1 inhibitor | 0.073 0.025 DBMET02759 0.057 0.047 DBMET02770 0.063 0.038 DBMET02761 | DBMET02759 | |
| 0.077 | 0.032 | 0.11 | Glutamate (mGluR7) antagonist | 0.081 0.026 DBMET02759 0.066 0.051 DBMET02768 0.077 0.032 DBMET02770 0.063 0.056 DBMET02760 0.066 0.051 DBMET02769 0.11 0.006 DBMET02761 0.073 0.038 DBMET02762 | DBMET02761 | |
| 0.048 | 0.005 | 0.048 | Alpha 1a adrenoreceptor agonist | |||
| 0.086 | 0.044 | 0.087 | Nicotinic alpha4beta2 receptor antagonist | 0.087 0.043 DBMET02761 | DBMET02761 | |
| 0.11 | 0.069 | 0.189 | Monophenol monooxygenase inhibitor | 0.106 0.072 DBMET02760 0.166 0.042 DBMET02761 0.189 0.036 DBMET02762 0.089 0.084 DBMET02765 | DBMET02762 | |
| 0.073 | 0.033 | 0.073 | 5 Hydroxytryptamine 3 agonist | 0.058 0.051 DBMET02759 0.068 0.038 DBMET02770 0.056 0.055 DBMET02769 0.067 0.039 DBMET02761 0.059 0.05 DBMET02762 | ||
| 0.11 | 0.07 | 0.11 | CDK3/cyclin E inhibitor | |||
| 0.079 | 0.04 | 0.133 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.084 0.031 DBMET02759 0.073 0.052 DBMET02768 0.076 0.046 DBMET02769 0.101 0.013 DBMET02761 0.133 0.004 DBMET02762 0.114 0.007 DBMET02765 0.098 0.015 DBMET02767 | DBMET02762 | |
| 0.092 | 0.054 | 0.228 | NADH dehydrogenase inhibitor | 0.15 0.017 DBMET02759 0.11 0.035 DBMET02768 0.098 0.046 DBMET02770 0.121 0.028 DBMET02760 0.12 0.029 DBMET02769 0.228 0.009 DBMET02761 0.112 0.033 DBMET02762 0.135 0.022 DBMET02765 0.111 0.034 DBMET02767 | DBMET02761 | |
| 0.256 | 0.219 | 0.522 | 5 Hydroxytryptamine release inhibitor | 0.243 0.238 DBMET02770 0.522 0.026 DBMET02761 0.335 0.129 DBMET02762 0.355 0.111 DBMET02765 0.258 0.217 DBMET02767 | DBMET02761 | |
| 0.039 | 0.004 | 0.044 | Glutaminyl-peptide cyclotransferase inhibitor | 0.044 0.004 DBMET02770 0.023 0.012 DBMET02762 | DBMET02770 | |
| 0.075 | 0.041 | 0.075 | Neuronal nicotinic receptor antagonist | 0.068 0.046 DBMET02761 | ||
| 0.067 | 0.036 | 0.237 | Carbamoyl phosphate synthetase inhibitor | 0.119 0.016 DBMET02759 0.09 0.024 DBMET02768 0.073 0.033 DBMET02770 0.096 0.022 DBMET02760 0.1 0.021 DBMET02769 0.237 0.006 DBMET02761 0.123 0.015 DBMET02762 0.124 0.015 DBMET02765 0.099 0.021 DBMET02767 | DBMET02761 | |
| 0.131 | 0.1 | 0.23 | Adenylate cyclase stimulant | 0.144 0.073 DBMET02759 0.134 0.092 DBMET02770 0.125 0.113 DBMET02760 0.141 0.079 DBMET02769 0.199 0.014 DBMET02761 0.194 0.017 DBMET02762 0.189 0.019 DBMET02765 0.23 0.005 DBMET02767 | DBMET02767 | |
| 0.076 | 0.048 | 0.268 | Glutamate decarboxylase inhibitor | 0.106 0.026 DBMET02759 0.081 0.043 DBMET02768 0.077 0.047 DBMET02770 0.112 0.024 DBMET02760 0.107 0.026 DBMET02769 0.216 0.005 DBMET02761 0.204 0.006 DBMET02762 0.187 0.008 DBMET02765 0.268 0.004 DBMET02767 | DBMET02767 | |
| 0.069 | 0.041 | 0.083 | MDM2 inhibitor | 0.072 0.034 DBMET02770 0.083 0.017 DBMET02761 | DBMET02761 | |
| 0.131 | 0.104 | 0.131 | MAP kinase 3 inhibitor | 0.126 0.117 DBMET02761 0.125 0.12 DBMET02762 | ||
| 0.129 | 0.102 | 0.161 | Pregnane X receptor agonist | 0.127 0.108 DBMET02768 0.142 0.068 DBMET02769 0.161 0.035 DBMET02761 | DBMET02761 | |
| 0.117 | 0.09 | 0.153 | Papain-like protease (SARS coronavirus) inhibitor | 0.134 0.054 DBMET02770 0.153 0.031 DBMET02762 | DBMET02762 | |
| 0.071 | 0.045 | 0.086 | Protein kinase C beta inhibitor | 0.077 0.035 DBMET02759 0.066 0.057 DBMET02770 0.082 0.028 DBMET02762 0.086 0.023 DBMET02765 | DBMET02765 | |
| 0.231 | 0.204 | 0.281 | DNA polymerase beta inhibitor | 0.281 0.175 DBMET02770 | DBMET02770 | |
| 0.037 | 0.01 | 0.037 | Nicotinic alpha4beta2 receptor agonist | 0.028 0.02 DBMET02770 0.035 0.012 DBMET02761 0.027 0.022 DBMET02762 | ||
| 0.094 | 0.068 | 0.169 | Electrolyte absorption antagonist | 0.123 0.034 DBMET02759 0.098 0.06 DBMET02770 0.159 0.016 DBMET02760 0.169 0.014 DBMET02761 0.099 0.059 DBMET02762 | DBMET02761 | |
| 0.085 | 0.059 | 0.161 | Calcium antagonist | 0.161 0.02 DBMET02761 | DBMET02761 | |
| 0.088 | 0.063 | 0.361 | Triose-phosphate isomerase inhibitor | 0.083 0.071 DBMET02759 0.095 0.053 DBMET02768 0.113 0.037 DBMET02770 0.081 0.075 DBMET02760 0.11 0.039 DBMET02769 0.361 0.004 DBMET02761 0.133 0.026 DBMET02762 0.137 0.024 DBMET02765 0.114 0.036 DBMET02767 | DBMET02761 | |
| 0.101 | 0.076 | 0.111 | CDC-like kinase 3 inhibitor | 0.097 0.087 DBMET02770 0.111 0.056 DBMET02761 | DBMET02761 | |
| 0.054 | 0.029 | 0.064 | Potassium channel (Inward rectifier) activator | 0.064 0.016 DBMET02761 0.049 0.038 DBMET02762 | DBMET02761 | |
| 0.031 | 0.006 | 0.083 | Histamine H4 receptor agonist | 0.083 0.003 DBMET02762 0.028 0.007 DBMET02765 | DBMET02762 | |
| 0.062 | 0.037 | 0.062 | Phosphodiesterase 1A inhibitor | 0.056 0.052 DBMET02770 0.059 0.043 DBMET02761 | ||
| 0.051 | 0.027 | 0.061 | Potassium channel (ATP-sensitive) activator | 0.061 0.015 DBMET02761 0.047 0.036 DBMET02762 | DBMET02761 | |
| 0.036 | 0.013 | 0.037 | Nicotinic alpha3beta4 receptor agonist | 0.032 0.018 DBMET02770 0.037 0.013 DBMET02761 | DBMET02761 | |
| 0.063 | 0.04 | 0.063 | Cyclin B1 inhibitor | |||
| 0.027 | 0.005 | 0.027 | Alpha 2b adrenoreceptor agonist | 0.019 0.013 DBMET02761 | ||
| 0.078 | 0.057 | 0.08 | Acetylcholine nicotinic antagonist | 0.08 0.054 DBMET02761 | DBMET02761 | |
| 0.111 | 0.092 | 0.17 | DNA repair enzyme inhibitor | 0.17 0.018 DBMET02759 0.114 0.085 DBMET02770 0.124 0.064 DBMET02760 0.141 0.04 DBMET02761 0.126 0.061 DBMET02762 0.113 0.088 DBMET02765 | DBMET02759 | |
| 0.034 | 0.014 | 0.034 | CDK4/cyclin D3 inhibitor | |||
| 0.136 | 0.118 | 0.152 | Tumour necrosis factor antagonist | 0.152 0.099 DBMET02761 | DBMET02761 | |
| 0.035 | 0.018 | 0.035 | Potassium channel small-conductance Ca-activated activator | 0.035 0.019 DBMET02761 | ||
| 0.049 | 0.033 | 0.069 | Histamine H4 receptor antagonist | 0.069 0.013 DBMET02762 0.049 0.033 DBMET02765 | DBMET02762 | |
| 0.097 | 0.082 | 0.224 | DOPA decarboxylase inhibitor | 0.224 0.004 DBMET02761 0.117 0.048 DBMET02762 | DBMET02761 | |
| 0.075 | 0.06 | 0.092 | MAP kinase kinase 7 inhibitor | 0.078 0.054 DBMET02770 0.092 0.021 DBMET02761 0.088 0.028 DBMET02762 | DBMET02761 | |
| 0.055 | 0.04 | 0.055 | Cyclin B2 inhibitor | |||
| 0.023 | 0.008 | 0.023 | Alpha 2c adrenoreceptor agonist | |||
| 0.058 | 0.044 | 0.059 | CXC chemokine 4 receptor antagonist | 0.059 0.043 DBMET02770 | DBMET02770 | |
| 0.129 | 0.116 | 0.237 | Melanin inhibitor | 0.141 0.094 DBMET02770 0.237 0.031 DBMET02761 0.164 0.064 DBMET02762 | DBMET02761 | |
| 0.141 | 0.129 | 0.462 | Succinate dehydrogenase inhibitor | 0.2 0.049 DBMET02759 0.168 0.083 DBMET02768 0.138 0.136 DBMET02770 0.191 0.057 DBMET02760 0.177 0.071 DBMET02769 0.462 0.003 DBMET02761 0.195 0.053 DBMET02762 0.214 0.039 DBMET02765 0.183 0.064 DBMET02767 | DBMET02761 | |
| 0.088 | 0.076 | 0.169 | Lanosterol 14 alpha demethylase inhibitor | 0.169 0.007 DBMET02761 | DBMET02761 | |
| 0.048 | 0.037 | 0.056 | Potassium channel (Inward rectifier) blocker | 0.056 0.027 DBMET02762 | DBMET02762 | |
| 0.022 | 0.013 | 0.023 | Imidazoline I1 receptor antagonist | 0.023 0.012 DBMET02761 | DBMET02761 | |
| 0.093 | 0.085 | 0.217 | Cystathionine beta-synthase inhibitor | 0.109 0.067 DBMET02759 0.111 0.066 DBMET02760 0.217 0.021 DBMET02761 | DBMET02761 | |
| 0.055 | 0.046 | 0.184 | Biliverdin reductase inhibitor | 0.089 0.022 DBMET02759 0.063 0.038 DBMET02770 0.064 0.036 DBMET02760 0.184 0.007 DBMET02761 0.087 0.023 DBMET02762 | DBMET02761 | |
| 0.074 | 0.066 | 0.074 | Adrenaline agonist | |||
| 0.21 | 0.202 | 0.326 | 15-Lipoxygenase inhibitor | 0.326 0.114 DBMET02759 0.219 0.193 DBMET02769 0.245 0.169 DBMET02761 | DBMET02759 | |
| 0.019 | 0.011 | 0.019 | Granulocyte colony stimulating factor receptor agonist | |||
| 0.079 | 0.072 | 0.115 | mTOR complex 2 inhibitor | 0.115 0.02 DBMET02761 0.102 0.031 DBMET02762 | DBMET02761 | |
| 0.02 | 0.014 | 0.02 | Hexokinase stimulant | |||
| 0.027 | 0.02 | 0.035 | Myristoyl transferase inhibitor | 0.035 0.008 DBMET02769 | DBMET02769 | |
| 0.05 | 0.044 | 0.094 | Alpha-mannosidase inhibitor | 0.067 0.019 DBMET02759 0.058 0.03 DBMET02768 0.052 0.039 DBMET02770 0.094 0.007 DBMET02760 0.062 0.024 DBMET02769 0.076 0.013 DBMET02761 0.062 0.024 DBMET02762 0.081 0.011 DBMET02765 0.067 0.019 DBMET02767 | DBMET02760 | |
| 0.017 | 0.011 | 0.017 | Nicotinic alpha4 receptor agonist | 0.015 0.013 DBMET02761 | ||
| 0.087 | 0.082 | 0.318 | Urease inhibitor | 0.122 0.044 DBMET02759 0.102 0.064 DBMET02760 0.115 0.05 DBMET02761 0.318 0.004 DBMET02762 0.135 0.032 DBMET02765 0.109 0.057 DBMET02767 | DBMET02762 | |
| 0.011 | 0.008 | 0.011 | Imidazoline I2 receptor antagonist | 0.01 0.008 DBMET02761 | ||
| 0.053 | 0.05 | 0.078 | Carbonic anhydrase stimulant | 0.071 0.031 DBMET02761 0.078 0.027 DBMET02762 0.058 0.043 DBMET02765 | DBMET02762 | |
| 0.042 | 0.04 | 0.042 | AMPA receptor antagonist | |||
| 0.024 | 0.022 | 0.029 | Complement factor 1s inhibitor | 0.027 0.014 DBMET02769 0.029 0.009 DBMET02761 0.025 0.019 DBMET02762 | DBMET02761 | |
| 0.047 | 0.046 | 0.211 | Acyl-CoA dehydrogenase inhibitor | 0.116 0.013 DBMET02759 0.056 0.036 DBMET02770 0.077 0.023 DBMET02760 0.211 0.005 DBMET02761 0.132 0.011 DBMET02762 0.081 0.022 DBMET02765 0.052 0.04 DBMET02767 | DBMET02761 | |
| 0.027 | 0.026 | 0.029 | MAP3K8 inhibitor | 0.029 0.02 DBMET02761 | DBMET02761 | |
| 0.06 | 0.058 | 0.156 | Phenylalanine 4-hydroxylase inhibitor | 0.066 0.05 DBMET02759 0.06 0.058 DBMET02768 0.074 0.042 DBMET02760 0.07 0.046 DBMET02769 0.156 0.011 DBMET02761 0.135 0.015 DBMET02762 0.108 0.022 DBMET02765 0.078 0.039 DBMET02767 | DBMET02761 | |
| 0.065 | 0.065 | 0.31 | Glutamate dehydrogenase inhibitor | 0.145 0.017 DBMET02759 0.079 0.045 DBMET02768 0.116 0.024 DBMET02760 0.087 0.039 DBMET02769 0.31 0.005 DBMET02761 0.149 0.016 DBMET02762 0.152 0.015 DBMET02765 0.117 0.024 DBMET02767 | DBMET02761 | |
| 0.09 | 0.091 | 0.175 | GABA receptor agonist | 0.139 0.042 DBMET02769 0.175 0.025 DBMET02767 | DBMET02767 | |
| 0.061 | 0.063 | 0.113 | Glutamate (mGluR6) antagonist | 0.113 0.007 DBMET02761 0.08 0.024 DBMET02762 | DBMET02761 | |
| 0.014 | 0.016 | 0.033 | Carbonic anhydrase X inhibitor | 0.016 0.012 DBMET02759 0.033 0.004 DBMET02761 0.025 0.005 DBMET02762 0.015 0.013 DBMET02765 | DBMET02761 | |
| 0.014 | 0.016 | 0.033 | Carbonic anhydrase VIII inhibitor | 0.016 0.012 DBMET02759 0.033 0.004 DBMET02761 0.025 0.005 DBMET02762 0.015 0.013 DBMET02765 | DBMET02761 | |
| 0.043 | 0.044 | 0.125 | Glucose-6-phosphate isomerase inhibitor | 0.052 0.027 DBMET02759 0.053 0.025 DBMET02768 0.051 0.028 DBMET02760 0.055 0.023 DBMET02769 0.125 0.003 DBMET02761 0.053 0.025 DBMET02762 0.068 0.013 DBMET02765 0.057 0.022 DBMET02767 | DBMET02761 | |
| 0.158 | 0.16 | 0.295 | Interleukin agonist | 0.165 0.154 DBMET02759 0.283 0.057 DBMET02770 0.295 0.05 DBMET02761 0.278 0.06 DBMET02762 0.227 0.097 DBMET02765 | DBMET02761 | |
| 0.077 | 0.079 | 0.123 | Estrogen-related receptor beta agonist | 0.08 0.066 DBMET02759 0.079 0.07 DBMET02770 0.079 0.07 DBMET02760 0.123 0.009 DBMET02761 0.089 0.042 DBMET02762 0.084 0.053 DBMET02765 | DBMET02761 | |
| 0.057 | 0.06 | 0.233 | Phosphofructokinase-1 inhibitor | 0.157 0.017 DBMET02759 0.085 0.038 DBMET02768 0.124 0.024 DBMET02760 0.094 0.034 DBMET02769 0.233 0.008 DBMET02761 0.114 0.027 DBMET02762 0.127 0.023 DBMET02765 0.093 0.034 DBMET02767 | DBMET02761 | |
| 0.027 | 0.03 | 0.06 | Sirtuin 2 inhibitor | 0.058 0.01 DBMET02770 0.038 0.019 DBMET02761 0.06 0.01 DBMET02762 | DBMET02762 | |
| 0.012 | 0.015 | 0.014 | Cyclin D2 inhibitor | 0.014 0.007 DBMET02761 | DBMET02761 | |
| 0.043 | 0.047 | 0.103 | Ornithine carbamoyltransferase inhibitor | 0.078 0.022 DBMET02759 0.063 0.03 DBMET02768 0.062 0.03 DBMET02760 0.067 0.027 DBMET02769 0.103 0.015 DBMET02761 0.067 0.027 DBMET02762 0.097 0.017 DBMET02765 0.072 0.025 DBMET02767 | DBMET02761 | |
| 0.031 | 0.037 | 0.042 | Glutamate (mGluR3) antagonist | 0.042 0.018 DBMET02761 | DBMET02761 | |
| 0.01 | 0.016 | 0.017 | Carbonic anhydrase XI inhibitor | 0.015 0.006 DBMET02761 0.017 0.005 DBMET02762 | DBMET02762 | |
| 0.042 | 0.049 | 0.095 | Topoisomerase II beta inhibitor | 0.095 0.01 DBMET02761 0.067 0.018 DBMET02762 | DBMET02761 | |
| 0.017 | 0.024 | 0.026 | Geranylgeranyltransferase inhibitor | 0.026 0.011 DBMET02759 | DBMET02759 | |
| 0.053 | 0.062 | 0.074 | Ryanodine receptor antagonist | 0.065 0.026 DBMET02770 0.074 0.013 DBMET02761 0.058 0.044 DBMET02762 | DBMET02761 | |
| 0.02 | 0.029 | 0.038 | CXC chemokine 2 receptor antagonist | 0.026 0.018 DBMET02759 0.038 0.009 DBMET02760 0.027 0.018 DBMET02761 | DBMET02760 | |
| 0.038 | 0.047 | 0.049 | Glutamate (mGluR group III) antagonist | 0.049 0.022 DBMET02761 | DBMET02761 | |
| 0.045 | 0.054 | 0.331 | Argininosuccinate synthase inhibitor | 0.065 0.033 DBMET02759 0.331 0.003 DBMET02761 0.084 0.024 DBMET02762 0.078 0.026 DBMET02765 0.05 0.047 DBMET02767 | DBMET02761 | |
| 0.179 | 0.191 | 0.334 | Transcription factor NF kappa B inhibitor | 0.334 0.082 DBMET02761 0.234 0.139 DBMET02762 | DBMET02761 | |
| 0.079 | 0.092 | 0.093 | Potassium channel (Voltage-sensitive) activator | 0.089 0.069 DBMET02759 0.093 0.063 DBMET02761 | DBMET02761 | |
| 0.047 | 0.06 | 0.055 | Cyclin-dependent kinase 6 inhibitor | 0.052 0.051 DBMET02759 0.055 0.047 DBMET02770 0.052 0.051 DBMET02761 | DBMET02770 | |
| 0.048 | 0.061 | 0.093 | Androgen agonist | 0.093 0.017 DBMET02761 | DBMET02761 | |
| 0.08 | 0.094 | 0.179 | Falcipain 3 inhibitor | 0.179 0.025 DBMET02761 0.097 0.074 DBMET02762 0.089 0.082 DBMET02765 | DBMET02761 | |
| 0.091 | 0.106 | 0.102 | MAP kinase kinase inhibitor | 0.102 0.093 DBMET02769 | DBMET02769 | |
| 0.064 | 0.079 | 0.076 | Phosphodiesterase VI inhibitor | 0.076 0.049 DBMET02761 | DBMET02761 | |
| 0.023 | 0.038 | 0.044 | Purinergic P2Y15 antagonist | 0.036 0.01 DBMET02759 0.029 0.019 DBMET02760 0.044 0.005 DBMET02761 0.041 0.006 DBMET02762 0.032 0.014 DBMET02765 | DBMET02761 | |
| 0.053 | 0.068 | 0.085 | Histone deacetylase inhibitor | 0.058 0.057 DBMET02770 0.085 0.027 DBMET02761 0.071 0.039 DBMET02762 | DBMET02761 | |
| 0.035 | 0.05 | 0.088 | Mannosidase inhibitor | 0.057 0.019 DBMET02759 0.043 0.035 DBMET02768 0.088 0.007 DBMET02760 0.048 0.028 DBMET02769 0.064 0.014 DBMET02761 0.049 0.026 DBMET02762 0.076 0.01 DBMET02765 0.06 0.016 DBMET02767 | DBMET02760 | |
| 0.042 | 0.057 | 0.172 | Aconitate hydratase inhibitor | 0.172 0.004 DBMET02761 0.065 0.022 DBMET02762 0.047 0.044 DBMET02765 | DBMET02761 | |
| 0.017 | 0.032 | 0.052 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.052 0.009 DBMET02759 0.035 0.015 DBMET02760 0.041 0.012 DBMET02761 | DBMET02759 | |
| 0.133 | 0.149 | 0.212 | Aryl hydrocarbon receptor agonist | 0.212 0.096 DBMET02759 0.203 0.101 DBMET02761 | DBMET02759 | |
| 0.021 | 0.038 | 0.032 | Acid ceramidase inhibitor | 0.026 0.015 DBMET02770 0.032 0.007 DBMET02761 | DBMET02761 | |
| 0.035 | 0.052 | 0.067 | Kainate receptor agonist | 0.067 0.005 DBMET02761 0.048 0.016 DBMET02762 | DBMET02761 | |
| 0.011 | 0.029 | 0.018 | Purinergic P2Y1 agonist | 0.018 0.008 DBMET02759 0.015 0.011 DBMET02760 0.017 0.009 DBMET02761 0.015 0.012 DBMET02762 0.015 0.011 DBMET02765 | DBMET02759 | |
| 0.03 | 0.049 | 0.049 | MAP3K5 inhibitor | 0.049 0.014 DBMET02761 | DBMET02761 | |
| 0.032 | 0.051 | 0.062 | Adenosine deaminase inhibitor | 0.062 0.019 DBMET02759 0.045 0.035 DBMET02768 0.059 0.021 DBMET02760 0.046 0.034 DBMET02769 0.057 0.023 DBMET02761 0.044 0.036 DBMET02762 0.044 0.036 DBMET02765 | DBMET02759 | |
| 0.032 | 0.051 | 0.048 | Thymidine kinase inhibitor | 0.041 0.028 DBMET02759 0.048 0.021 DBMET02761 0.038 0.034 DBMET02762 | DBMET02761 | |
| 0.027 | 0.046 | 0.032 | Protein kinase (CK2) beta inhibitor | 0.032 0.027 DBMET02761 | DBMET02761 | |
| 0.03 | 0.049 | 0.057 | Membrane dipeptidase inhibitor | 0.057 0.011 DBMET02761 0.048 0.017 DBMET02762 0.055 0.012 DBMET02765 0.043 0.022 DBMET02767 | DBMET02761 | |
| 0.077 | 0.096 | 0.109 | Protein kinase C zeta inhibitor | 0.091 0.064 DBMET02759 0.109 0.041 DBMET02765 | DBMET02765 | |
| 0.029 | 0.049 | 0.057 | Oxytocin agonist | 0.045 0.027 DBMET02770 0.057 0.019 DBMET02761 0.051 0.023 DBMET02762 0.047 0.026 DBMET02765 | DBMET02761 | |
| 0.076 | 0.096 | 0.089 | Polo-like kinase-1 inhibitor | 0.089 0.063 DBMET02770 0.083 0.075 DBMET02762 | DBMET02770 | |
| 0.043 | 0.064 | 0.067 | Nicotinic alpha3beta2 receptor antagonist | 0.067 0.02 DBMET02761 | DBMET02761 | |
| 0.058 | 0.079 | 0.078 | Secretase beta inhibitor | 0.078 0.039 DBMET02761 | DBMET02761 | |
| 0.077 | 0.099 | 0.153 | Carbonic anhydrase III inhibitor | 0.106 0.056 DBMET02759 0.095 0.068 DBMET02760 0.106 0.055 DBMET02769 0.153 0.027 DBMET02761 0.12 0.044 DBMET02762 0.105 0.057 DBMET02765 0.088 0.078 DBMET02767 | DBMET02761 | |
| 0.078 | 0.101 | 0.289 | Nitric-oxide synthase inhibitor | 0.118 0.039 DBMET02761 0.289 0.004 DBMET02762 0.229 0.006 DBMET02765 0.159 0.019 DBMET02767 | DBMET02762 | |
| 0.012 | 0.035 | 0.022 | Adenosine kinase inhibitor | 0.022 0.014 DBMET02759 | DBMET02759 | |
| 0.026 | 0.049 | 0.053 | Factor XIIIa inhibitor | 0.053 0.014 DBMET02761 | DBMET02761 | |
| 0.073 | 0.097 | 0.337 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.105 0.049 DBMET02759 0.337 0.005 DBMET02761 0.11 0.046 DBMET02762 | DBMET02761 | |
| 0.01 | 0.034 | 0.018 | Alpha 2a adrenoreceptor agonist | 0.018 0.011 DBMET02761 | DBMET02761 | |
| 0.073 | 0.097 | 0.1 | CC chemokine 5 receptor agonist | 0.1 0.021 DBMET02761 | DBMET02761 | |
| 0.052 | 0.076 | 0.084 | Carbonic anhydrase VA inhibitor | 0.08 0.037 DBMET02759 0.084 0.034 DBMET02761 0.084 0.034 DBMET02762 0.078 0.038 DBMET02765 0.064 0.054 DBMET02767 | DBMET02762 | |
| 0.022 | 0.046 | 0.029 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.029 0.013 DBMET02761 | DBMET02761 | |
| 0.055 | 0.08 | 0.165 | Aminopeptidase I inhibitor | 0.075 0.047 DBMET02759 0.074 0.049 DBMET02760 0.165 0.01 DBMET02761 0.097 0.029 DBMET02762 0.067 0.057 DBMET02765 | DBMET02761 | |
| 0.016 | 0.041 | 0.026 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.026 0.006 DBMET02761 | DBMET02761 | |
| 0.105 | 0.131 | 0.23 | Mannose-6-phosphate isomerase inhibitor | 0.23 0.017 DBMET02759 0.204 0.029 DBMET02760 0.212 0.024 DBMET02761 0.123 0.096 DBMET02762 | DBMET02759 | |
| 0.048 | 0.074 | 0.098 | Immunoglobulin Fc receptor antagonist | 0.069 0.012 DBMET02761 0.098 0.004 DBMET02762 0.058 0.029 DBMET02765 | DBMET02762 | |
| 0.034 | 0.06 | 0.042 | CF transmembrane conductance regulator antagonist | 0.042 0.02 DBMET02761 | DBMET02761 | |
| 0.112 | 0.138 | 0.202 | Thiol protease inhibitor | 0.129 0.099 DBMET02759 0.202 0.038 DBMET02761 0.186 0.045 DBMET02762 | DBMET02761 | |
| 0.022 | 0.049 | 0.036 | Estrogen-related receptor gamma antagonist | 0.036 0.008 DBMET02761 0.027 0.024 DBMET02765 | DBMET02761 | |
| 0.016 | 0.044 | 0.027 | Lysine carboxypeptidase inhibitor | 0.027 0.019 DBMET02761 | DBMET02761 | |
| 0.017 | 0.045 | 0.035 | Lysophosphatidic acid receptor 1 agonist | 0.035 0.007 DBMET02761 0.023 0.022 DBMET02762 | DBMET02761 | |
| 0.027 | 0.056 | 0.082 | Dopamine D5 agonist | 0.082 0.006 DBMET02761 0.044 0.023 DBMET02762 | DBMET02761 | |
| 0.015 | 0.043 | 0.048 | Uridine phosphorylase inhibitor | 0.048 0.009 DBMET02761 0.029 0.018 DBMET02765 | DBMET02761 | |
| 0.041 | 0.07 | 0.056 | Nicotinic receptor alpha7 subunit antagonist | 0.05 0.044 DBMET02759 0.056 0.033 DBMET02761 | DBMET02761 | |
| 0.052 | 0.081 | 0.106 | Na+ K+ transporting ATPase inhibitor | 0.067 0.063 DBMET02769 0.106 0.026 DBMET02761 0.092 0.039 DBMET02762 0.102 0.03 DBMET02765 0.087 0.043 DBMET02767 | DBMET02761 | |
| 0.071 | 0.1 | 0.159 | Phosphodiesterase I inhibitor | 0.159 0.016 DBMET02759 0.089 0.06 DBMET02760 0.087 0.063 DBMET02761 | DBMET02759 | |
| 0.11 | 0.14 | 0.241 | Arachidonic acid antagonist | 0.131 0.111 DBMET02768 0.135 0.107 DBMET02769 0.241 0.008 DBMET02761 0.154 0.083 DBMET02762 0.174 0.06 DBMET02765 0.138 0.103 DBMET02767 | DBMET02761 | |
| 0.021 | 0.052 | 0.036 | Epoxide hydrolase 1 inhibitor | 0.036 0.014 DBMET02761 0.035 0.016 DBMET02762 | DBMET02761 | |
| 0.021 | 0.052 | 0.196 | Fumarate hydratase inhibitor | 0.038 0.02 DBMET02759 0.196 0.003 DBMET02761 0.034 0.024 DBMET02762 | DBMET02761 | |
| 0.014 | 0.046 | 0.033 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.033 0.015 DBMET02761 | DBMET02761 | |
| 0.021 | 0.053 | 0.03 | Glucosylceramidase stimulant | 0.03 0.013 DBMET02761 | DBMET02761 | |
| 0.014 | 0.046 | 0.434 | CYP24 inhibitor | 0.024 0.015 DBMET02768 0.434 0.001 DBMET02769 | DBMET02769 | |
| 0.028 | 0.061 | 0.075 | Guanylate cyclase inhibitor | 0.066 0.007 DBMET02759 0.04 0.034 DBMET02768 0.065 0.008 DBMET02760 0.04 0.033 DBMET02769 0.075 0.004 DBMET02761 0.045 0.026 DBMET02765 | DBMET02761 | |
| 0.048 | 0.082 | 0.074 | Corticotropin releasing factor 2 receptor antagonist | 0.074 0.023 DBMET02761 | DBMET02761 | |
| 0.013 | 0.047 | 0.022 | Methylmalonyl-CoA mutase inhibitor | 0.018 0.013 DBMET02759 0.022 0.005 DBMET02761 | DBMET02761 | |
| 0.024 | 0.058 | 0.042 | Toll-Like receptor 2 agonist | 0.042 0.028 DBMET02761 0.039 0.031 DBMET02762 0.036 0.034 DBMET02765 | DBMET02761 | |
| 0.16 | 0.194 | 0.311 | 12-Lipoxygenase inhibitor | 0.311 0.074 DBMET02759 0.26 0.103 DBMET02760 0.272 0.096 DBMET02761 0.272 0.097 DBMET02762 | DBMET02759 | |
| 0.076 | 0.11 | 0.21 | DNA intercalator | 0.21 0.023 DBMET02762 0.09 0.086 DBMET02765 | DBMET02762 | |
| 0.02 | 0.055 | 0.034 | Methionyl aminopeptidase 1 inhibitor | 0.034 0.019 DBMET02761 | DBMET02761 | |
| 0.024 | 0.059 | 0.119 | Melatonin receptor 1A agonist | 0.041 0.013 DBMET02761 0.119 0.003 DBMET02762 | DBMET02762 | |
| 0.005 | 0.041 | 0.024 | Lysophosphatidic acid receptor 3 agonist | 0.024 0.004 DBMET02761 | DBMET02761 | |
| 0.04 | 0.076 | 0.059 | Heparanase inhibitor | 0.059 0.025 DBMET02761 | DBMET02761 | |
| 0.079 | 0.115 | 0.117 | Beta glucuronidase inhibitor | 0.093 0.082 DBMET02760 0.117 0.048 DBMET02761 | DBMET02761 | |
| 0.013 | 0.049 | 0.051 | Glutamate (mGluR1a) agonist | 0.039 0.006 DBMET02769 0.045 0.005 DBMET02761 0.051 0.005 DBMET02767 | DBMET02767 | |
| 0.073 | 0.11 | 0.127 | Interleukin 1 beta converting enzyme inhibitor | 0.127 0.03 DBMET02761 | DBMET02761 | |
| 0.056 | 0.094 | 0.073 | Adenosine A3 receptor antagonist | 0.073 0.054 DBMET02761 | DBMET02761 | |
| 0.061 | 0.099 | 0.108 | Vanilloid 4 agonist | 0.069 0.068 DBMET02770 0.108 0.012 DBMET02761 0.074 0.054 DBMET02762 | DBMET02761 | |
| 0.007 | 0.045 | 0.018 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.018 0.004 DBMET02761 | DBMET02761 | |
| 0.01 | 0.049 | 0.026 | Telomerase stimulant | 0.026 0.004 DBMET02761 | DBMET02761 | |
| 0.041 | 0.08 | 0.085 | Epithelial sodium channel blocker | 0.058 0.032 DBMET02761 0.07 0.018 DBMET02762 0.085 0.011 DBMET02765 0.064 0.024 DBMET02767 | DBMET02765 | |
| 0.128 | 0.167 | 0.202 | Neurotensin receptor agonist | 0.18 0.05 DBMET02761 0.174 0.057 DBMET02762 0.202 0.033 DBMET02765 0.171 0.061 DBMET02767 | DBMET02765 | |
| 0.001 | 0.041 | 0.004 | Human herpesvirus 2 protease inhibitor | 0.004 0.002 DBMET02761 | DBMET02761 | |
| 0.006 | 0.047 | 0.011 | Purine nucleoside phosphorylase inhibitor | 0.011 0.009 DBMET02760 | DBMET02760 | |
| 0.155 | 0.196 | 0.326 | Prostaglandin dehydrogenase inhibitor | 0.326 0.091 DBMET02759 0.177 0.175 DBMET02770 0.291 0.106 DBMET02760 | DBMET02759 | |
| 0.032 | 0.073 | 0.05 | Glutamate (mGluR4) antagonist | 0.05 0.02 DBMET02761 | DBMET02761 | |
| 0.049 | 0.091 | 0.088 | Acetylcholine M4 receptor antagonist | 0.088 0.039 DBMET02761 | DBMET02761 | |
| 0.086 | 0.128 | 0.323 | Aldehyde dehydrogenase inhibitor | 0.163 0.04 DBMET02759 0.107 0.087 DBMET02760 0.323 0.01 DBMET02761 0.278 0.014 DBMET02762 0.195 0.029 DBMET02765 0.1 0.098 DBMET02767 | DBMET02761 | |
| 0.059 | 0.102 | 0.128 | Glycine receptor antagonist | 0.076 0.064 DBMET02770 0.128 0.014 DBMET02761 0.074 0.067 DBMET02762 0.09 0.043 DBMET02765 | DBMET02761 | |
| 0.015 | 0.058 | 0.063 | Endothelial nitric-oxide synthase inhibitor | 0.031 0.022 DBMET02761 0.063 0.007 DBMET02762 0.046 0.011 DBMET02765 | DBMET02762 | |
| 0.069 | 0.112 | 0.15 | Granulocyte macrophage colony stimulating factor agonist | 0.15 0.005 DBMET02761 0.091 0.05 DBMET02762 | DBMET02761 | |
| 0.044 | 0.088 | 0.067 | Heat shock protein 90 beta antagonist | 0.067 0.03 DBMET02761 | DBMET02761 | |
| 0.042 | 0.086 | 0.085 | Carbonic anhydrase V inhibitor | 0.072 0.041 DBMET02759 0.083 0.034 DBMET02761 0.078 0.037 DBMET02762 0.085 0.033 DBMET02765 0.066 0.047 DBMET02767 | DBMET02765 | |
| 0.005 | 0.049 | 0.021 | Immunosuppressant Cyclosporine-like | 0.021 0.003 DBMET02770 | DBMET02770 | |
| 0.045 | 0.09 | 0.262 | Catalase inhibitor | 0.262 0.008 DBMET02761 0.09 0.042 DBMET02762 0.071 0.054 DBMET02765 | DBMET02761 | |
| 0.129 | 0.173 | 0.304 | Neurotrophic factor enhancer | 0.304 0.017 DBMET02761 0.174 0.105 DBMET02762 | DBMET02761 | |
| 0.049 | 0.093 | 0.076 | Interferon inducer | 0.076 0.028 DBMET02759 0.068 0.037 DBMET02760 0.075 0.029 DBMET02761 0.059 0.057 DBMET02765 | DBMET02759 | |
| 0.065 | 0.11 | 0.086 | Potassium channel activator | 0.083 0.071 DBMET02761 0.086 0.065 DBMET02762 | DBMET02762 | |
| 0.038 | 0.083 | 0.057 | 5 Hydroxytryptamine 2A agonist | 0.057 0.05 DBMET02761 | DBMET02761 | |
| 0.027 | 0.074 | 0.064 | Glutamate (mGluR8) agonist | 0.064 0.006 DBMET02761 0.043 0.018 DBMET02762 | DBMET02761 | |
| 0.003 | 0.05 | 0.008 | DNA topoisomerase III inhibitor | 0.008 0.005 DBMET02761 | DBMET02761 | |
| 0.053 | 0.102 | 0.129 | Exportin-1 inhibitor | 0.129 0.004 DBMET02761 0.073 0.037 DBMET02762 | DBMET02761 | |
| 0.004 | 0.054 | 0.015 | Glutamate (mGluR6) agonist | 0.015 0.005 DBMET02761 | DBMET02761 | |
| 0.05 | 0.1 | 0.137 | Histone deacetylase SIRT3 inhibitor | 0.065 0.036 DBMET02761 0.137 0.005 DBMET02762 0.067 0.032 DBMET02765 | DBMET02762 | |
| 0.012 | 0.062 | 0.049 | Arginase inhibitor | 0.045 0.019 DBMET02761 0.049 0.016 DBMET02762 0.038 0.024 DBMET02765 | DBMET02762 | |
| 0.167 | 0.217 | 0.486 | Vasodilator, peripheral | 0.281 0.107 DBMET02770 0.203 0.172 DBMET02760 0.486 0.031 DBMET02761 0.216 0.158 DBMET02762 0.213 0.162 DBMET02765 | DBMET02761 | |
| 0.03 | 0.081 | 0.073 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.073 0.004 DBMET02761 0.047 0.018 DBMET02762 0.066 0.005 DBMET02765 0.055 0.01 DBMET02767 | DBMET02761 | |
| 0.039 | 0.09 | 0.107 | Acetylcholine M5 receptor agonist | 0.066 0.048 DBMET02770 0.107 0.016 DBMET02761 | DBMET02761 | |
| 0.016 | 0.067 | 0.041 | Vanilloid 2 agonist | 0.041 0.004 DBMET02761 0.031 0.009 DBMET02762 0.031 0.008 DBMET02765 0.027 0.014 DBMET02767 | DBMET02761 | |
| 0.012 | 0.065 | 0.028 | Acetylcholine M4 receptor agonist | 0.028 0.024 DBMET02761 | DBMET02761 | |
| 0.087 | 0.14 | 0.146 | Nav1.6 sodium channel blocker | 0.146 0.059 DBMET02761 | DBMET02761 | |
| 0.025 | 0.08 | 0.044 | Tryptophan 5 hydroxylase inhibitor | 0.044 0.009 DBMET02761 | DBMET02761 | |
| 0.013 | 0.068 | 0.026 | Isoleucine-tRNA ligase inhibitor | 0.026 0.009 DBMET02761 | DBMET02761 | |
| 0.02 | 0.076 | 0.035 | Hedgehog signaling activator | 0.035 0.007 DBMET02761 0.026 0.025 DBMET02762 | DBMET02761 | |
| 0.059 | 0.116 | 0.157 | GABA B receptor agonist | 0.079 0.044 DBMET02769 0.111 0.01 DBMET02761 0.088 0.028 DBMET02762 0.106 0.013 DBMET02765 0.157 0.004 DBMET02767 | DBMET02767 | |
| 0.024 | 0.08 | 0.12 | Ribonucleoside-diphosphate reductase inhibitor | 0.047 0.043 DBMET02759 0.061 0.033 DBMET02761 0.12 0.016 DBMET02762 | DBMET02762 | |
| 0.044 | 0.1 | 0.339 | Polo-like kinase-2 inhibitor | 0.339 0.002 DBMET02759 | DBMET02759 | |
| 0.024 | 0.081 | 0.044 | Antimetabolite | 0.044 0.036 DBMET02762 | DBMET02762 | |
| 0.066 | 0.123 | 0.102 | Bromodomain-containing protein 2 inhibitor | 0.102 0.038 DBMET02761 | DBMET02761 | |
| 0.045 | 0.102 | 0.111 | Protease 3C (Human rhinovirus) inhibitor | 0.111 0.012 DBMET02761 0.077 0.029 DBMET02762 | DBMET02761 | |
| 0.023 | 0.081 | 0.119 | Ribonucleotide reductase inhibitor | 0.047 0.044 DBMET02759 0.063 0.035 DBMET02761 0.119 0.017 DBMET02762 | DBMET02762 | |
| 0.04 | 0.097 | 0.054 | 5 Hydroxytryptamine 7 agonist | 0.054 0.042 DBMET02761 | DBMET02761 | |
| 0.022 | 0.08 | 0.032 | ATR kinase inhibitor | 0.032 0.025 DBMET02762 | DBMET02762 | |
| 0.029 | 0.088 | 0.059 | GABA B receptor antagonist | 0.059 0.013 DBMET02761 0.046 0.024 DBMET02767 | DBMET02761 | |
| 0.058 | 0.116 | 0.207 | Aminopeptidase B inhibitor | 0.122 0.051 DBMET02759 0.097 0.067 DBMET02760 0.207 0.02 DBMET02761 0.145 0.04 DBMET02762 0.175 0.028 DBMET02765 0.149 0.038 DBMET02767 | DBMET02761 | |
| 0.016 | 0.076 | 0.031 | Calcitonin receptor agonist | 0.031 0.026 DBMET02761 | DBMET02761 | |
| 0.027 | 0.088 | 0.05 | AICAR transformylase inhibitor | 0.05 0.022 DBMET02761 | DBMET02761 | |
| 0.034 | 0.095 | 0.052 | Heme oxygenase inhibitor | 0.052 0.01 DBMET02761 | DBMET02761 | |
| 0.016 | 0.077 | 0.053 | Phosphoglycerate kinase inhibitor | 0.053 0.013 DBMET02761 0.033 0.027 DBMET02765 | DBMET02761 | |
| 0.068 | 0.129 | 0.168 | Anabolic | 0.106 0.054 DBMET02759 0.096 0.069 DBMET02760 0.168 0.01 DBMET02761 0.1 0.062 DBMET02762 0.129 0.031 DBMET02765 0.107 0.053 DBMET02767 | DBMET02761 | |
| 0.009 | 0.071 | 0.062 | Geranylgeranyltransferase I inhibitor | 0.062 0.004 DBMET02759 | DBMET02759 | |
| 0.024 | 0.087 | 0.084 | Carbonic anhydrase I inhibitor | 0.084 0.023 DBMET02759 0.056 0.039 DBMET02760 0.053 0.041 DBMET02761 0.049 0.044 DBMET02762 | DBMET02759 | |
| 0.051 | 0.114 | 0.105 | Androgen antagonist | 0.105 0.043 DBMET02761 | DBMET02761 | |
| 0.013 | 0.076 | 0.026 | Factor XIII inhibitor | 0.026 0.006 DBMET02761 | DBMET02761 | |
| 0.053 | 0.117 | 0.109 | Interferon agonist | 0.109 0.022 DBMET02759 0.098 0.03 DBMET02760 0.098 0.03 DBMET02761 0.075 0.06 DBMET02765 | DBMET02759 | |
| 0.018 | 0.083 | 0.049 | Histone deacetylase class I inhibitor | 0.049 0.02 DBMET02761 | DBMET02761 | |
| 0.12 | 0.187 | 0.212 | Phospholipase C inhibitor | 0.159 0.089 DBMET02759 0.212 0.037 DBMET02761 0.187 0.054 DBMET02762 0.197 0.046 DBMET02765 0.165 0.08 DBMET02767 | DBMET02761 | |
| 0.015 | 0.083 | 0.024 | Integrin alpha2beta1 antagonist | 0.024 0.023 DBMET02761 | DBMET02761 | |
| 0.047 | 0.115 | 0.101 | Phospholipase D inhibitor | 0.066 0.063 DBMET02770 0.101 0.014 DBMET02761 0.072 0.049 DBMET02762 0.085 0.027 DBMET02765 | DBMET02761 | |
| 0.109 | 0.178 | 0.189 | CF transmembrane conductance regulator agonist | 0.189 0.029 DBMET02761 0.149 0.077 DBMET02762 | DBMET02761 | |
| 0.025 | 0.095 | 0.047 | Nicotinic receptor alpha3 subunit antagonist | 0.047 0.028 DBMET02761 | DBMET02761 | |
| 0.02 | 0.091 | 0.035 | Ceramide glucosyltransferase inhibitor | 0.033 0.031 DBMET02760 0.035 0.026 DBMET02761 | DBMET02761 | |
| 0.059 | 0.131 | 0.11 | Caspase 7 inhibitor | 0.11 0.02 DBMET02761 | DBMET02761 | |
| 0.033 | 0.106 | 0.07 | Squalene epoxidase inhibitor | 0.07 0.014 DBMET02761 | DBMET02761 | |
| 0.019 | 0.091 | 0.085 | Histone deacetylase 7 inhibitor | 0.085 0.01 DBMET02761 | DBMET02761 | |
| 0.171 | 0.244 | 0.432 | Histamine release inhibitor | 0.205 0.196 DBMET02768 0.22 0.18 DBMET02769 0.432 0.059 DBMET02761 0.243 0.161 DBMET02762 0.259 0.149 DBMET02765 | DBMET02761 | |
| 0.027 | 0.101 | 0.086 | Carbonic anhydrase inhibitor | 0.086 0.032 DBMET02759 0.057 0.049 DBMET02761 | DBMET02759 | |
| 0.022 | 0.096 | 0.041 | Glutamate (mGluR1a) antagonist | 0.041 0.028 DBMET02761 | DBMET02761 | |
| 0.021 | 0.096 | 0.097 | Carbonic anhydrase VB inhibitor | 0.084 0.021 DBMET02759 0.084 0.021 DBMET02761 0.078 0.023 DBMET02762 0.097 0.017 DBMET02765 0.076 0.024 DBMET02767 | DBMET02765 | |
| 0.026 | 0.102 | 0.087 | Adenylate cyclase 1 inhibitor | 0.087 0.005 DBMET02761 | DBMET02761 | |
| 0.023 | 0.1 | 0.064 | Xanthine dehydrogenase inhibitor | 0.064 0.035 DBMET02760 | DBMET02760 | |
| 0.031 | 0.108 | 0.059 | Lysine-specific demethylase 1A inhibitor | 0.059 0.029 DBMET02762 | DBMET02762 | |
| 0.015 | 0.094 | 0.095 | Carbonic anhydrase XII inhibitor | 0.095 0.021 DBMET02759 | DBMET02759 | |
| 0.02 | 0.099 | 0.078 | Carbonic anhydrase II inhibitor | 0.078 0.026 DBMET02759 0.05 0.044 DBMET02760 0.051 0.043 DBMET02761 | DBMET02759 | |
| 0.056 | 0.135 | 0.123 | Glutathione S-transferase inhibitor | 0.123 0.021 DBMET02761 | DBMET02761 | |
| 0.032 | 0.112 | 0.046 | Bombesin 2 receptor antagonist | 0.046 0.04 DBMET02761 0.045 0.043 DBMET02765 | DBMET02761 | |
| 0.024 | 0.104 | 0.056 | Potassium channel Kv1.1 blocker | 0.056 0.01 DBMET02761 0.035 0.033 DBMET02762 | DBMET02761 | |
| 0.023 | 0.105 | 0.061 | Histone deacetylase 9 inhibitor | 0.061 0.011 DBMET02761 | DBMET02761 | |
| 0.055 | 0.137 | 0.191 | HIV-1 integrase (Overall Integration) inhibitor | 0.161 0.021 DBMET02759 0.145 0.027 DBMET02760 0.191 0.013 DBMET02761 0.141 0.029 DBMET02765 0.099 0.055 DBMET02767 | DBMET02761 | |
| 0.097 | 0.179 | 0.128 | LIM domain kinase 1 inhibitor | 0.128 0.124 DBMET02762 | DBMET02762 | |
| 0.009 | 0.092 | 0.019 | Estrogen-related receptor gamma agonist | 0.019 0.011 DBMET02761 | DBMET02761 | |
| 0.024 | 0.107 | 0.048 | Adenosine uptake inhibitor | 0.048 0.005 DBMET02761 | DBMET02761 | |
| 0.075 | 0.158 | 0.196 | Photosensitizer | 0.196 0.014 DBMET02761 0.097 0.095 DBMET02762 0.107 0.075 DBMET02765 | DBMET02761 | |
| 0.044 | 0.128 | 0.083 | Phosphodiesterase 1C inhibitor | 0.083 0.018 DBMET02759 0.064 0.039 DBMET02760 0.06 0.048 DBMET02761 | DBMET02759 | |
| 0.036 | 0.119 | 0.096 | Dihydroorotate oxidase inhibitor | 0.096 0.005 DBMET02761 | DBMET02761 | |
| 0.011 | 0.095 | 0.026 | Neuraminidase (Influenza B) inhibitor | 0.026 0.007 DBMET02761 | DBMET02761 | |
| 0.017 | 0.102 | 0.033 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.033 0.026 DBMET02761 | DBMET02761 | |
| 0.047 | 0.132 | 0.098 | MAO A inhibitor | 0.098 0.066 DBMET02762 | DBMET02762 | |
| 0.022 | 0.108 | 0.038 | AMPA 4 receptor antagonist | 0.038 0.029 DBMET02761 | DBMET02761 | |
| 0.02 | 0.106 | 0.041 | Glutamate (mGluR3) agonist | 0.041 0.009 DBMET02761 0.037 0.013 DBMET02762 | DBMET02761 | |
| 0.006 | 0.092 | 0.018 | Thromboxane A2 agonist | 0.018 0.008 DBMET02761 | DBMET02761 | |
| 0.101 | 0.187 | 0.148 | MAP kinase kinase 2 inhibitor | 0.148 0.123 DBMET02761 0.137 0.133 DBMET02762 | DBMET02761 | |
| 0.07 | 0.157 | 0.17 | Microtubule formation inhibitor | 0.17 0.029 DBMET02761 0.105 0.082 DBMET02762 | DBMET02761 | |
| 0.067 | 0.154 | 0.15 | Acetylcholine antagonist | 0.15 0.05 DBMET02761 | DBMET02761 | |
| 0.068 | 0.156 | 0.16 | Cholinergic antagonist | 0.16 0.047 DBMET02761 | DBMET02761 | |
| 0.066 | 0.154 | 0.269 | Alkylator | 0.115 0.073 DBMET02760 0.269 0.015 DBMET02769 0.137 0.054 DBMET02761 0.116 0.072 DBMET02762 0.127 0.062 DBMET02765 0.172 0.036 DBMET02767 | DBMET02769 | |
| 0.039 | 0.127 | 0.082 | Pregnane X receptor antagonist | 0.082 0.005 DBMET02761 | DBMET02761 | |
| 0.036 | 0.125 | 0.123 | Purinergic P2X1 antagonist | 0.08 0.025 DBMET02759 0.061 0.041 DBMET02760 0.058 0.046 DBMET02769 0.123 0.011 DBMET02761 0.065 0.036 DBMET02765 | DBMET02761 | |
| 0.006 | 0.095 | 0.021 | Nicotinic acid receptor 1 antagonist | 0.021 0.008 DBMET02761 | DBMET02761 | |
| 0.152 | 0.241 | 0.398 | Calpain 2 inhibitor | 0.339 0.092 DBMET02759 0.244 0.153 DBMET02770 0.398 0.062 DBMET02761 0.218 0.173 DBMET02762 | DBMET02761 | |
| 0.016 | 0.106 | 0.035 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.035 0.01 DBMET02762 | DBMET02762 | |
| 0.04 | 0.129 | 0.066 | Aryl hydrocarbon receptor antagonist | 0.066 0.043 DBMET02761 | DBMET02761 | |
| 0.025 | 0.115 | 0.073 | Lysophosphatidic acid 3 receptor antagonist | 0.073 0.013 DBMET02761 0.046 0.043 DBMET02765 | DBMET02761 | |
| 0.021 | 0.111 | 0.05 | Fructose-1,6-bisphosphatase inhibitor | 0.05 0.025 DBMET02761 | DBMET02761 | |
| 0.012 | 0.102 | 0.057 | Carbonic anhydrase IV inhibitor | 0.047 0.027 DBMET02761 0.057 0.02 DBMET02762 0.039 0.034 DBMET02765 | DBMET02762 | |
| 0.166 | 0.257 | 0.366 | Interleukin 2 agonist | 0.366 0.039 DBMET02770 0.21 0.173 DBMET02762 | DBMET02770 | |
| 0.029 | 0.121 | 0.06 | HCV NS3/NS4A protease inhibitor | 0.06 0.021 DBMET02761 | DBMET02761 | |
| 0.066 | 0.157 | 0.187 | Carbonic anhydrase XV inhibitor | 0.095 0.075 DBMET02769 0.187 0.021 DBMET02761 0.111 0.054 DBMET02762 0.127 0.042 DBMET02765 0.108 0.057 DBMET02767 | DBMET02761 | |
| 0.019 | 0.112 | 0.041 | Retinoid X alpha receptor antagonist | 0.041 0.014 DBMET02761 | DBMET02761 | |
| 0.014 | 0.106 | 0.046 | Glutamate (mGluR1) agonist | 0.03 0.009 DBMET02761 0.024 0.019 DBMET02762 0.023 0.021 DBMET02765 0.046 0.005 DBMET02767 | DBMET02767 | |
| 0.046 | 0.139 | 0.088 | I kappa B kinase inhibitor | 0.088 0.05 DBMET02762 | DBMET02762 | |
| 0.011 | 0.105 | 0.037 | Nicotinic acid receptor 2 antagonist | 0.037 0.006 DBMET02761 | DBMET02761 | |
| 0.013 | 0.107 | 0.059 | Diamine oxidase inhibitor | 0.057 0.011 DBMET02761 0.051 0.014 DBMET02762 0.059 0.01 DBMET02765 0.038 0.025 DBMET02767 | DBMET02765 | |
| 0.026 | 0.12 | 0.087 | NMDA receptor glycine site agonist | 0.078 0.03 DBMET02770 0.087 0.024 DBMET02761 0.069 0.037 DBMET02762 0.054 0.053 DBMET02765 | DBMET02761 | |
| 0.118 | 0.213 | 0.268 | Antioxidant | 0.268 0.075 DBMET02761 0.176 0.136 DBMET02765 | DBMET02761 | |
| 0.019 | 0.115 | 0.044 | Delayed rectifier potassium channel blocker | 0.044 0.016 DBMET02761 | DBMET02761 | |
| 0.015 | 0.11 | 0.059 | Cyclophilin A inhibitor | 0.047 0.008 DBMET02770 0.059 0.005 DBMET02761 | DBMET02761 | |
| 0.025 | 0.121 | 0.044 | CC chemokine 4 receptor antagonist | 0.044 0.038 DBMET02761 | DBMET02761 | |
| 0.013 | 0.11 | 0.052 | Peptide deformylase inhibitor | 0.052 0.009 DBMET02761 0.044 0.012 DBMET02765 | DBMET02761 | |
| 0.03 | 0.127 | 0.075 | Cytokine production stimulant | 0.047 0.037 DBMET02759 0.075 0.006 DBMET02761 0.05 0.029 DBMET02762 | DBMET02761 | |
| 0.038 | 0.135 | 0.136 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.077 0.053 DBMET02759 0.136 0.023 DBMET02761 | DBMET02761 | |
| 0.025 | 0.122 | 0.048 | 5 Hydroxytryptamine 4 antagonist | 0.048 0.041 DBMET02761 | DBMET02761 | |
| 0.018 | 0.116 | 0.037 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.037 0.026 DBMET02761 | DBMET02761 | |
| 0.009 | 0.107 | 0.025 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.025 0.014 DBMET02761 | DBMET02761 | |
| 0.112 | 0.211 | 0.42 | Spasmolytic | 0.21 0.112 DBMET02761 0.194 0.125 DBMET02762 0.2 0.119 DBMET02765 0.42 0.036 DBMET02767 | DBMET02767 | |
| 0.007 | 0.106 | 0.016 | Vitamin D receptor agonist | 0.016 0.012 DBMET02761 | DBMET02761 | |
| 0.043 | 0.142 | 0.13 | Ornithine decarboxylase inhibitor | 0.13 0.019 DBMET02761 0.085 0.062 DBMET02762 | DBMET02761 | |
| 0.021 | 0.121 | 0.047 | Retinoid X receptor antagonist | 0.047 0.016 DBMET02761 | DBMET02761 | |
| 0.035 | 0.136 | 0.136 | NMDA receptor agonist | 0.065 0.041 DBMET02770 0.081 0.028 DBMET02761 0.087 0.025 DBMET02762 0.074 0.033 DBMET02765 0.136 0.01 DBMET02767 | DBMET02767 | |
| 0.046 | 0.148 | 0.134 | Glycine receptor agonist | 0.134 0.009 DBMET02761 | DBMET02761 | |
| 0.031 | 0.133 | 0.092 | Sphingosine 1-phosphate receptor 4 agonist | 0.092 0.029 DBMET02761 0.074 0.041 DBMET02762 | DBMET02761 | |
| 0.009 | 0.113 | 0.028 | Antibiotic Anthracycline-like | 0.028 0.004 DBMET02761 | DBMET02761 | |
| 0.046 | 0.151 | 0.117 | Carbonic anhydrase VI inhibitor | 0.117 0.031 DBMET02761 0.073 0.067 DBMET02762 0.074 0.066 DBMET02765 | DBMET02761 | |
| 0.033 | 0.138 | 0.073 | Benzodiazepine agonist | 0.073 0.047 DBMET02770 0.065 0.058 DBMET02761 | DBMET02770 | |
| 0.01 | 0.115 | 0.046 | 5-Alpha-reductase inhibitor | 0.046 0.02 DBMET02761 | DBMET02761 | |
| 0.051 | 0.156 | 0.134 | Sphingomyelinase inhibitor | 0.134 0.032 DBMET02761 0.123 0.039 DBMET02762 | DBMET02761 | |
| 0.025 | 0.13 | 0.07 | NMDA 2 receptor antagonist | 0.07 0.051 DBMET02765 | DBMET02765 | |
| 0.011 | 0.117 | 0.04 | Kainate receptor antagonist | 0.04 0.029 DBMET02761 | DBMET02761 | |
| 0.008 | 0.113 | 0.017 | CC chemokine 9 receptor antagonist | 0.017 0.013 DBMET02761 | DBMET02761 | |
| 0.127 | 0.233 | 0.224 | MAP-kinase-activated kinase 5 inhibitor | 0.218 0.083 DBMET02770 0.224 0.078 DBMET02762 0.19 0.116 DBMET02765 | DBMET02762 | |
| 0.003 | 0.109 | 0.015 | Calcineurin inhibitor | 0.015 0.005 DBMET02770 | DBMET02770 | |
| 0.128 | 0.234 | 0.21 | Lipoxygenase inhibitor | 0.21 0.13 DBMET02761 | DBMET02761 | |
| 0.022 | 0.128 | 0.037 | 5 Hydroxytryptamine 2B agonist | 0.037 0.03 DBMET02761 | DBMET02761 | |
| 0.082 | 0.189 | 0.202 | Psychostimulant | 0.202 0.079 DBMET02761 0.154 0.113 DBMET02762 | DBMET02761 | |
| 0.099 | 0.206 | 0.164 | I kappa B kinase epsilon inhibitor | 0.164 0.105 DBMET02761 | DBMET02761 | |
| 0.021 | 0.129 | 0.065 | Dihydroorotase inhibitor | 0.065 0.013 DBMET02761 | DBMET02761 | |
| 0.08 | 0.189 | 0.121 | Transcription factor STAT6 inhibitor | 0.121 0.058 DBMET02761 0.112 0.077 DBMET02762 | DBMET02761 | |
| 0.014 | 0.124 | 0.052 | Dihydropteroate synthase inhibitor | 0.044 0.022 DBMET02761 0.036 0.033 DBMET02762 0.052 0.015 DBMET02765 0.043 0.023 DBMET02767 | DBMET02765 | |
| 0.048 | 0.158 | 0.273 | Inducible nitric-oxide synthase inhibitor | 0.119 0.025 DBMET02761 0.273 0.005 DBMET02762 0.248 0.005 DBMET02765 0.155 0.015 DBMET02767 | DBMET02762 | |
| 0.017 | 0.131 | 0.062 | Aromatase inhibitor | 0.062 0.04 DBMET02761 | DBMET02761 | |
| 0.024 | 0.14 | 0.05 | Benzodiazepine antagonist | 0.05 0.028 DBMET02761 | DBMET02761 | |
| 0.01 | 0.126 | 0.025 | Retinoid X beta receptor antagonist | 0.025 0.007 DBMET02761 | DBMET02761 | |
| 0.02 | 0.136 | 0.043 | Glutamate (mGluR5) agonist | 0.043 0.036 DBMET02769 | DBMET02769 | |
| 0.058 | 0.175 | 0.093 | Xanthine oxidase inhibitor | 0.093 0.067 DBMET02761 | DBMET02761 | |
| 0.114 | 0.234 | 0.264 | Calpain inhibitor | 0.207 0.107 DBMET02759 0.264 0.052 DBMET02761 0.181 0.133 DBMET02762 | DBMET02761 | |
| 0.073 | 0.195 | 0.14 | Interleukin 8 antagonist | 0.101 0.095 DBMET02760 0.14 0.041 DBMET02761 0.105 0.086 DBMET02765 | DBMET02761 | |
| 0.007 | 0.13 | 0.031 | Kynurenine 3 monooxygenase inhibitor | 0.031 0.015 DBMET02761 | DBMET02761 | |
| 0.025 | 0.149 | 0.215 | Protein kinase C eta inhibitor | 0.215 0.004 DBMET02759 0.049 0.045 DBMET02760 0.12 0.012 DBMET02762 0.154 0.007 DBMET02765 0.098 0.018 DBMET02767 | DBMET02759 | |
| 0.023 | 0.148 | 0.059 | Beta 1 adrenoreceptor antagonist | 0.059 0.037 DBMET02761 | DBMET02761 | |
| 0.068 | 0.193 | 0.112 | CDC-like kinase 1 inhibitor | 0.112 0.104 DBMET02761 | DBMET02761 | |
| 0.032 | 0.159 | 0.052 | Glucosylceramidase inhibitor | 0.052 0.044 DBMET02761 | DBMET02761 | |
| 0.026 | 0.153 | 0.043 | Dipeptidyl peptidase IV inhibitor | 0.043 0.034 DBMET02770 | DBMET02770 | |
| 0.009 | 0.136 | 0.041 | Protease (Human cytomegalovirus) inhibitor | 0.041 0.005 DBMET02761 | DBMET02761 | |
| 0.136 | 0.264 | 0.246 | Neuropeptide Y2 antagonist | 0.177 0.166 DBMET02770 0.246 0.06 DBMET02761 0.214 0.096 DBMET02762 | DBMET02761 | |
| 0.032 | 0.16 | 0.082 | Phosphodiesterase 1B inhibitor | 0.082 0.021 DBMET02759 | DBMET02759 | |
| 0.005 | 0.134 | 0.016 | Melatonin receptor 1A antagonist | 0.016 0.007 DBMET02762 | DBMET02762 | |
| 0.047 | 0.177 | 0.1 | MAO inhibitor | 0.1 0.091 DBMET02762 | DBMET02762 | |
| 0.019 | 0.151 | 0.058 | Dihydrofolate reductase inhibitor | 0.042 0.033 DBMET02761 0.058 0.012 DBMET02762 0.042 0.035 DBMET02765 | DBMET02762 | |
| 0.099 | 0.232 | 0.151 | Focal adhesion kinase 2 inhibitor | 0.144 0.14 DBMET02761 0.151 0.129 DBMET02762 | DBMET02762 | |
| 0.073 | 0.206 | 0.177 | Protein kinase stimulant | 0.118 0.095 DBMET02759 0.177 0.051 DBMET02761 | DBMET02761 | |
| 0.057 | 0.19 | 0.112 | Beta amyloid protein antagonist | 0.112 0.075 DBMET02761 | DBMET02761 | |
| 0.02 | 0.154 | 0.065 | Acetylcholine M5 receptor antagonist | 0.065 0.035 DBMET02761 | DBMET02761 | |
| 0.01 | 0.145 | 0.054 | Nicotinic acid receptor agonist | 0.054 0.013 DBMET02761 | DBMET02761 | |
| 0.009 | 0.146 | 0.04 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.04 0.016 DBMET02761 | DBMET02761 | |
| 0.057 | 0.194 | 0.174 | Mucolytic | 0.151 0.032 DBMET02759 0.093 0.088 DBMET02768 0.119 0.055 DBMET02760 0.102 0.074 DBMET02769 0.174 0.021 DBMET02761 0.095 0.085 DBMET02762 0.143 0.037 DBMET02765 0.111 0.064 DBMET02767 | DBMET02761 | |
| 0.008 | 0.145 | 0.05 | Carbonic anhydrase IX inhibitor | 0.05 0.043 DBMET02759 | DBMET02759 | |
| 0.052 | 0.192 | 0.117 | Bile acid receptor antagonist | 0.086 0.084 DBMET02769 0.117 0.022 DBMET02761 | DBMET02761 | |
| 0.029 | 0.169 | 0.05 | Dipeptidyl peptidase inhibitor | 0.05 0.042 DBMET02770 | DBMET02770 | |
| 0.008 | 0.149 | 0.043 | Cathepsin L1 inhibitor | 0.04 0.027 DBMET02761 0.043 0.024 DBMET02762 | DBMET02762 | |
| 0.083 | 0.224 | 0.169 | Sphingosine 1-phosphate receptor 2 antagonist | 0.169 0.022 DBMET02761 0.118 0.102 DBMET02762 0.116 0.108 DBMET02765 | DBMET02761 | |
| 0.049 | 0.191 | 0.139 | Chelator | 0.103 0.074 DBMET02761 0.139 0.04 DBMET02762 | DBMET02762 | |
| 0.024 | 0.167 | 0.08 | Aldosterone antagonist | 0.08 0.011 DBMET02761 | DBMET02761 | |
| 0.042 | 0.186 | 0.074 | Transcription factor RelA inhibitor | 0.074 0.024 DBMET02761 | DBMET02761 | |
| 0.042 | 0.187 | 0.142 | Keratolytic | 0.142 0.016 DBMET02761 | DBMET02761 | |
| 0.009 | 0.154 | 0.032 | Prostaglandin F2 alpha agonist | 0.032 0.008 DBMET02761 | DBMET02761 | |
| 0.008 | 0.155 | 0.104 | Kinesin antagonist | 0.104 0.007 DBMET02762 | DBMET02762 | |
| 0.008 | 0.155 | 0.104 | Kinesin-like protein 1 inhibitor | 0.104 0.007 DBMET02762 | DBMET02762 | |
| 0.014 | 0.161 | 0.053 | GABA uptake inhibitor | 0.053 0.014 DBMET02761 | DBMET02761 | |
| 0.026 | 0.173 | 0.073 | Sphingosine kinase 2 inhibitor | 0.073 0.02 DBMET02761 0.054 0.041 DBMET02762 0.053 0.042 DBMET02765 | DBMET02761 | |
| 0.017 | 0.164 | 0.031 | Glutamate (mGluR4) agonist | 0.031 0.029 DBMET02769 0.031 0.03 DBMET02767 | DBMET02767 | |
| 0.052 | 0.2 | 0.156 | Acetylcholine muscarinic antagonist | 0.156 0.04 DBMET02761 | DBMET02761 | |
| 0.074 | 0.222 | 0.175 | Phospholipase A2 inhibitor | 0.175 0.057 DBMET02761 | DBMET02761 | |
| 0.005 | 0.153 | 0.022 | NMDA receptor glycine site antagonist | 0.022 0.02 DBMET02761 | DBMET02761 | |
| 0.022 | 0.171 | 0.047 | Vanilloid 3 antagonist | 0.047 0.011 DBMET02761 | DBMET02761 | |
| 0.032 | 0.182 | 0.116 | Cyclin-dependent kinase 1 inhibitor | 0.116 0.057 DBMET02759 | DBMET02759 | |
| 0.059 | 0.209 | 0.119 | mTOR complex 1 inhibitor | 0.119 0.029 DBMET02770 | DBMET02770 | |
| 0.023 | 0.175 | 0.044 | Purinergic P2X4 antagonist | 0.044 0.037 DBMET02761 | DBMET02761 | |
| 0.089 | 0.241 | 0.194 | Interferon gamma antagonist | 0.194 0.043 DBMET02761 | DBMET02761 | |
| 0.028 | 0.18 | 0.116 | Carbonic anhydrase XIII inhibitor | 0.116 0.031 DBMET02761 | DBMET02761 | |
| 0.123 | 0.275 | 0.413 | Cholesterol antagonist | 0.329 0.074 DBMET02759 0.193 0.171 DBMET02768 0.259 0.119 DBMET02760 0.215 0.151 DBMET02769 0.413 0.047 DBMET02761 0.238 0.134 DBMET02765 | DBMET02761 | |
| 0.024 | 0.177 | 0.074 | Phosphodiesterase 7A inhibitor | 0.074 0.009 DBMET02770 | DBMET02770 | |
| 0.002 | 0.156 | 0.011 | Thromboxane agonist | 0.011 0.007 DBMET02761 | DBMET02761 | |
| 0.072 | 0.226 | 0.268 | Dual specificity phosphatase 3 inhibitor | 0.268 0.035 DBMET02759 0.163 0.085 DBMET02768 0.2 0.061 DBMET02760 0.206 0.057 DBMET02769 0.246 0.042 DBMET02765 0.152 0.095 DBMET02767 | DBMET02759 | |
| 0.068 | 0.222 | 0.233 | Acetylcholine M1 receptor antagonist | 0.233 0.03 DBMET02761 | DBMET02761 | |
| 0.033 | 0.187 | 0.097 | NMDA receptor antagonist | 0.097 0.049 DBMET02767 | DBMET02767 | |
| 0.112 | 0.267 | 0.206 | Beta lactamase inhibitor | 0.206 0.181 DBMET02770 | DBMET02770 | |
| 0.01 | 0.166 | 0.025 | Thyroid hormone agonist | 0.025 0.019 DBMET02761 | DBMET02761 | |
| 0.035 | 0.191 | 0.061 | Beta 3 adrenoreceptor antagonist | 0.061 0.052 DBMET02761 | DBMET02761 | |
| 0.009 | 0.166 | 0.021 | Caspase 8 inhibitor | 0.021 0.011 DBMET02761 | DBMET02761 | |
| 0.081 | 0.239 | 0.162 | Vanilloid 1 agonist | 0.162 0.028 DBMET02761 0.15 0.038 DBMET02762 | DBMET02761 | |
| 0.005 | 0.163 | 0.018 | Complement factor D inhibitor | 0.018 0.013 DBMET02761 | DBMET02761 | |
| 0.078 | 0.242 | 0.219 | Dual specificity phosphatase inhibitor | 0.189 0.061 DBMET02759 0.149 0.095 DBMET02768 0.147 0.098 DBMET02760 0.184 0.064 DBMET02769 0.219 0.046 DBMET02765 0.138 0.109 DBMET02767 | DBMET02765 | |
| 0.09 | 0.254 | 0.183 | Sphingosine 1-phosphate receptor 5 antagonist | 0.183 0.021 DBMET02761 | DBMET02761 | |
| 0.03 | 0.195 | 0.071 | Potassium channel intermediate-conductance Ca-activated blocker | 0.071 0.025 DBMET02761 | DBMET02761 | |
| 0.022 | 0.188 | 0.081 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.081 0.016 DBMET02761 | DBMET02761 | |
| 0.045 | 0.212 | 0.08 | Estrogen receptor alpha antagonist | 0.08 0.048 DBMET02761 | DBMET02761 | |
| 0.071 | 0.238 | 0.192 | Sphingosine 1-phosphate receptor 4 antagonist | 0.192 0.011 DBMET02761 | DBMET02761 | |
| 0.014 | 0.183 | 0.05 | Stearoyl-CoA desaturase inhibitor | 0.05 0.023 DBMET02761 | DBMET02761 | |
| 0.116 | 0.285 | 0.23 | Hypoxia-inducible factor 1 alpha inhibitor | 0.23 0.119 DBMET02761 | DBMET02761 | |
| 0.014 | 0.185 | 0.064 | Cathepsin L inhibitor | 0.064 0.035 DBMET02761 0.062 0.037 DBMET02762 | DBMET02761 | |
| 0.061 | 0.232 | 0.213 | TRPA1 agonist | 0.213 0.008 DBMET02761 | DBMET02761 | |
| 0.033 | 0.205 | 0.153 | Anesthetic local | 0.153 0.047 DBMET02761 | DBMET02761 | |
| 0.033 | 0.204 | 0.109 | GABA aminotransferase inhibitor | 0.109 0.021 DBMET02761 0.076 0.051 DBMET02762 | DBMET02761 | |
| 0.015 | 0.187 | 0.045 | Carbonic anhydrase XIV inhibitor | 0.045 0.039 DBMET02761 | DBMET02761 | |
| 0.034 | 0.208 | 0.086 | Potassium channel (Tandem pore domain) blocker | 0.086 0.022 DBMET02761 | DBMET02761 | |
| 0.049 | 0.228 | 0.14 | Adenylate cyclase inhibitor | 0.107 0.078 DBMET02759 0.14 0.052 DBMET02761 0.094 0.09 DBMET02765 | DBMET02761 | |
| 0.009 | 0.188 | 0.047 | Retinoid X alpha receptor agonist | 0.047 0.016 DBMET02761 | DBMET02761 | |
| 0.021 | 0.203 | 0.067 | Amidase inhibitor | 0.067 0.054 DBMET02761 | DBMET02761 | |
| 0.037 | 0.22 | 0.059 | Beta 2 adrenoreceptor agonist | 0.059 0.056 DBMET02761 | DBMET02761 | |
| 0.003 | 0.187 | 0.016 | Human herpes virus 5 capsid protein P40 inhibitor | 0.016 0.005 DBMET02761 | DBMET02761 | |
| 0.01 | 0.194 | 0.048 | NMDA receptor subunit 3A antagonist | 0.048 0.021 DBMET02767 | DBMET02767 | |
| 0.038 | 0.222 | 0.126 | Mediator release inhibitor | 0.126 0.042 DBMET02761 | DBMET02761 | |
| 0.085 | 0.271 | 0.268 | 3C-like protease (Human coronavirus) inhibitor | 0.268 0.02 DBMET02761 | DBMET02761 | |
| 0.07 | 0.258 | 0.205 | Hexokinase inhibitor | 0.205 0.032 DBMET02761 | DBMET02761 | |
| 0.006 | 0.194 | 0.046 | Retinoid X receptor agonist | 0.046 0.019 DBMET02761 | DBMET02761 | |
| 0.014 | 0.202 | 0.053 | Acetylcholine M3 receptor antagonist | 0.053 0.05 DBMET02761 | DBMET02761 | |
| 0.016 | 0.205 | 0.045 | Sphingosine kinase 1 inhibitor | 0.045 0.023 DBMET02761 | DBMET02761 | |
| 0.036 | 0.227 | 0.149 | Expectorant | 0.129 0.045 DBMET02759 0.097 0.072 DBMET02760 0.149 0.036 DBMET02761 0.113 0.056 DBMET02765 | DBMET02761 | |
| 0.056 | 0.247 | 0.167 | Toll-Like receptor 2 antagonist | 0.167 0.041 DBMET02761 | DBMET02761 | |
| 0.081 | 0.273 | 0.222 | Non-steroidal antiinflammatory agent | 0.222 0.056 DBMET02761 0.138 0.133 DBMET02765 | DBMET02761 | |
| 0.016 | 0.211 | 0.063 | Prolyl endopeptidase inhibitor | 0.063 0.021 DBMET02761 | DBMET02761 | |
| 0.069 | 0.266 | 0.181 | Insulin sensitizer | 0.181 0.094 DBMET02761 0.173 0.103 DBMET02765 | DBMET02761 | |
| 0.1 | 0.297 | 0.229 | Catenin beta inhibitor | 0.229 0.017 DBMET02770 | DBMET02770 | |
| 0.026 | 0.224 | 0.063 | Beta adrenoreceptor antagonist | 0.063 0.05 DBMET02761 | DBMET02761 | |
| 0.054 | 0.253 | 0.202 | Cathepsin H inhibitor | 0.202 0.022 DBMET02761 0.119 0.076 DBMET02762 0.157 0.041 DBMET02765 0.126 0.068 DBMET02767 | DBMET02761 | |
| 0.068 | 0.27 | 0.162 | Heat shock protein 90 alpha antagonist | 0.162 0.076 DBMET02761 0.13 0.111 DBMET02762 | DBMET02761 | |
| 0.024 | 0.227 | 0.052 | Fatty acid synthase inhibitor | 0.052 0.047 DBMET02761 | DBMET02761 | |
| 0.054 | 0.257 | 0.169 | Cyclooxygenase 3 inhibitor | 0.169 0.034 DBMET02761 | DBMET02761 | |
| 0.006 | 0.213 | 0.026 | Sodium/glucose cotransporter 2 inhibitor | 0.026 0.018 DBMET02761 | DBMET02761 | |
| 0.053 | 0.264 | 0.124 | Glutamate (mGluR7) agonist | 0.124 0.027 DBMET02761 0.114 0.037 DBMET02762 | DBMET02761 | |
| 0.022 | 0.234 | 0.068 | Sphingosine kinase inhibitor | 0.068 0.027 DBMET02761 0.065 0.031 DBMET02765 | DBMET02761 | |
| 0.026 | 0.24 | 0.046 | CD45 antagonist | 0.046 0.044 DBMET02761 | DBMET02761 | |
| 0.01 | 0.225 | 0.044 | Angiotensin AT1 receptor antagonist | 0.044 0.026 DBMET02761 | DBMET02761 | |
| 0.017 | 0.233 | 0.062 | Glutamate (mGluR group III) agonist | 0.062 0.018 DBMET02767 | DBMET02767 | |
| 0.006 | 0.222 | 0.039 | Free fatty acid receptor 1 antagonist | 0.039 0.016 DBMET02761 | DBMET02761 | |
| 0.009 | 0.226 | 0.038 | ATP citrate lysase inhibitor | 0.038 0.015 DBMET02761 | DBMET02761 | |
| 0.04 | 0.257 | 0.112 | Cyclin-dependent kinase inhibitor | 0.112 0.079 DBMET02759 | DBMET02759 | |
| 0.011 | 0.231 | 0.033 | Angiotensin II receptor antagonist | 0.033 0.025 DBMET02761 | DBMET02761 | |
| 0.004 | 0.226 | 0.034 | Bradykinin B2 receptor antagonist | 0.034 0.02 DBMET02762 | DBMET02762 | |
| 0.009 | 0.232 | 0.035 | Lysophosphatidic acid 2 receptor antagonist | 0.035 0.016 DBMET02761 | DBMET02761 | |
| 0.007 | 0.231 | 0.054 | Oleamide hydrolase inhibitor | 0.054 0.024 DBMET02761 | DBMET02761 | |
| 0.01 | 0.236 | 0.053 | Potassium channel Kv1.3 blocker | 0.053 0.027 DBMET02761 | DBMET02761 | |
| 0.024 | 0.257 | 0.097 | Cathepsin G inhibitor | 0.097 0.034 DBMET02761 | DBMET02761 | |
| 0.108 | 0.343 | 0.305 | Vasodilator, coronary | 0.305 0.083 DBMET02759 0.294 0.093 DBMET02761 0.229 0.155 DBMET02765 | DBMET02759 | |
| 0.042 | 0.278 | 0.148 | Proteasome inhibitor | 0.148 0.047 DBMET02761 | DBMET02761 | |
| 0.01 | 0.248 | 0.112 | Leukocyte elastase inhibitor | 0.112 0.009 DBMET02761 | DBMET02761 | |
| 0.007 | 0.251 | 0.025 | Sodium/glucose cotransporter inhibitor | 0.025 0.02 DBMET02761 | DBMET02761 | |
| 0.008 | 0.256 | 0.057 | Carbonic anhydrase VII inhibitor | 0.057 0.021 DBMET02761 | DBMET02761 | |
| 0.031 | 0.282 | 0.168 | Cholesterol synthesis inhibitor | 0.168 0.037 DBMET02761 | DBMET02761 | |
| 0.039 | 0.291 | 0.819 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.819 0.003 DBMET02759 0.13 0.105 DBMET02762 | DBMET02759 | |
| 0.039 | 0.294 | 0.142 | Caspase 3 inhibitor | 0.142 0.034 DBMET02761 | DBMET02761 | |
| 0.039 | 0.299 | 0.075 | Calcium channel P-type blocker | 0.075 0.02 DBMET02761 | DBMET02761 | |
| 0.026 | 0.286 | 0.106 | Macrophage migration inhibitory factor inhibitor | 0.106 0.032 DBMET02761 | DBMET02761 | |
| 0.015 | 0.277 | 0.058 | Cholesterol esterase inhibitor | 0.058 0.02 DBMET02761 | DBMET02761 | |
| 0.066 | 0.33 | 0.17 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.17 0.105 DBMET02762 | DBMET02762 | |
| 0.016 | 0.283 | 0.049 | Leukotriene B4 antagonist | 0.049 0.046 DBMET02761 | DBMET02761 | |
| 0.03 | 0.298 | 0.505 | Protein kinase C mu inhibitor | 0.505 0.003 DBMET02759 0.119 0.043 DBMET02760 0.262 0.007 DBMET02762 0.325 0.005 DBMET02765 0.219 0.01 DBMET02767 | DBMET02759 | |
| 0.004 | 0.274 | 0.029 | Prostaglandin agonist | 0.029 0.024 DBMET02761 | DBMET02761 | |
| 0.019 | 0.29 | 0.075 | Epoxide hydrolase inhibitor | 0.075 0.047 DBMET02761 | DBMET02761 | |
| 0.019 | 0.292 | 0.043 | Leukotriene C4 antagonist | 0.043 0.018 DBMET02761 | DBMET02761 | |
| 0.028 | 0.303 | 0.065 | Leukotriene C antagonist | 0.065 0.019 DBMET02761 | DBMET02761 | |
| 0.048 | 0.323 | 0.11 | Nav1.2 sodium channel blocker | 0.11 0.096 DBMET02765 | DBMET02765 | |
| 0.055 | 0.332 | 0.129 | Neuropeptide Y1 antagonist | 0.124 0.114 DBMET02761 0.129 0.102 DBMET02762 | DBMET02762 | |
| 0.048 | 0.326 | 0.189 | Diuretic | 0.189 0.049 DBMET02759 0.162 0.067 DBMET02760 0.167 0.063 DBMET02761 | DBMET02759 | |
| 0.013 | 0.291 | 0.057 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.057 0.042 DBMET02761 | DBMET02761 | |
| 0.011 | 0.289 | 0.083 | Phosphodiesterase VII inhibitor | 0.083 0.023 DBMET02770 | DBMET02770 | |
| 0.049 | 0.334 | 0.139 | Heat shock protein 90 antagonist | 0.139 0.086 DBMET02761 | DBMET02761 | |
| 0.068 | 0.354 | 0.379 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.379 0.018 DBMET02762 0.213 0.082 DBMET02765 | DBMET02762 | |
| 0.018 | 0.306 | 0.174 | Protein kinase C alpha inhibitor | 0.174 0.007 DBMET02759 | DBMET02759 | |
| 0.004 | 0.301 | 0.026 | Purinergic P2X agonist | 0.025 0.02 DBMET02759 0.024 0.021 DBMET02768 0.026 0.02 DBMET02769 0.023 0.022 DBMET02765 | DBMET02769 | |
| 0.015 | 0.313 | 0.089 | ZAP-70 protein tyrosine kinase inhibitor | 0.089 0.023 DBMET02759 | DBMET02759 | |
| 0.079 | 0.38 | 0.403 | Immunosuppressant | 0.403 0.061 DBMET02761 | DBMET02761 | |
| 0.096 | 0.4 | 0.356 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.356 0.034 DBMET02760 | DBMET02760 | |
| 0.016 | 0.321 | 0.069 | Sphingosine 1-phosphate receptor 3 antagonist | 0.069 0.027 DBMET02761 | DBMET02761 | |
| 0.042 | 0.35 | 0.126 | Cytokine production inhibitor | 0.126 0.083 DBMET02761 | DBMET02761 | |
| 0.01 | 0.324 | 0.048 | Dihydroorotate dehydrogenase inhibitor | 0.048 0.039 DBMET02761 | DBMET02761 | |
| 0.012 | 0.331 | 0.113 | Protein kinase C epsilon inhibitor | 0.113 0.01 DBMET02759 0.095 0.014 DBMET02762 0.047 0.045 DBMET02765 | DBMET02759 | |
| 0.072 | 0.392 | 0.321 | Lipocortins synthesis antagonist | 0.321 0.018 DBMET02761 | DBMET02761 | |
| 0.018 | 0.339 | 0.057 | Sphingosine 1-phosphate receptor 1 antagonist | 0.057 0.036 DBMET02761 | DBMET02761 | |
| 0.005 | 0.339 | 0.215 | Histamine H3 receptor agonist | 0.141 0.005 DBMET02762 0.215 0.004 DBMET02765 0.082 0.007 DBMET02767 | DBMET02765 | |
| 0.005 | 0.342 | 0.091 | Histone deacetylase 1 inhibitor | 0.091 0.009 DBMET02761 | DBMET02761 | |
| 0.025 | 0.362 | 0.071 | Peroxisome proliferator-activated receptor gamma antagonist | 0.071 0.05 DBMET02761 | DBMET02761 | |
| 0.031 | 0.371 | 0.192 | Lipid peroxidase inhibitor | 0.192 0.045 DBMET02761 | DBMET02761 | |
| 0.004 | 0.35 | 0.044 | GP IIb/IIIa receptor antagonist | 0.044 0.038 DBMET02765 | DBMET02765 | |
| 0.015 | 0.368 | 0.221 | Human rhinovirus A protease inhibitor | 0.221 0.005 DBMET02761 | DBMET02761 | |
| 0.005 | 0.366 | 0.081 | Cyclin E inhibitor | 0.081 0.032 DBMET02759 | DBMET02759 | |
| 0.006 | 0.371 | 0.084 | Cyclin E1 inhibitor | 0.084 0.023 DBMET02759 | DBMET02759 | |
| 0.048 | 0.418 | 0.289 | Insulin secretagoues | 0.289 0.014 DBMET02769 0.173 0.054 DBMET02767 | DBMET02769 | |
| 0.018 | 0.393 | 0.211 | M18 aspartyl aminopeptidase inhibitor | 0.211 0.03 DBMET02759 0.186 0.038 DBMET02760 | DBMET02759 | |
| 0.018 | 0.394 | 0.268 | Protein-tyrosine kinase Lyn inhibitor | 0.268 0.025 DBMET02759 | DBMET02759 | |
| 0.015 | 0.399 | 0.18 | M17 leucyl aminopeptidase inhibitor | 0.18 0.04 DBMET02759 0.174 0.043 DBMET02770 0.147 0.057 DBMET02760 | DBMET02759 | |
| 0.031 | 0.421 | 0.342 | Anticoagulant | 0.342 0.022 DBMET02765 0.205 0.051 DBMET02767 | DBMET02765 | |
| 0.02 | 0.425 | 0.085 | Sphingosine 1-phosphate receptor antagonist | 0.085 0.037 DBMET02761 | DBMET02761 | |
| 0.09 | 0.502 | 0.367 | Apoptosis agonist | 0.367 0.13 DBMET02770 0.267 0.197 DBMET02761 0.334 0.149 DBMET02762 | DBMET02770 | |
| 0.015 | 0.435 | 0.114 | HIV-1 integrase inhibitor | 0.068 0.05 DBMET02760 0.114 0.018 DBMET02761 | DBMET02761 | |
| 0.043 | 0.508 | 0.483 | Hepatoprotectant | 0.334 0.022 DBMET02768 0.279 0.036 DBMET02761 0.483 0.008 DBMET02765 | DBMET02765 | |
| 0.012 | 0.477 | 0.118 | Protein kinase C iota inhibitor | 0.118 0.015 DBMET02759 0.076 0.028 DBMET02762 0.075 0.029 DBMET02765 | DBMET02759 | |
| 0.046 | 0.532 | 0.217 | Transcription factor STAT inhibitor | 0.217 0.115 DBMET02761 | DBMET02761 | |
| 0.101 | 0.592 | 0.201 | MAP kinase kinase 3 inhibitor | 0.201 0.12 DBMET02762 | DBMET02762 | |
| 0.03 | 0.538 | 0.152 | Hemostatic | 0.152 0.066 DBMET02765 | DBMET02765 | |
| 0.023 | 0.536 | 0.118 | Caspase 9 inhibitor | 0.118 0.009 DBMET02761 | DBMET02761 | |
| 0.036 | 0.55 | 0.232 | Transcription factor STAT3 inhibitor | 0.232 0.1 DBMET02761 | DBMET02761 | |
| 0.023 | 0.538 | 0.31 | Free radical scavenger | 0.15 0.145 DBMET02760 0.31 0.049 DBMET02761 | DBMET02761 | |
| 0.032 | 0.554 | 0.117 | Toll-Like receptor 3 antagonist | 0.117 0.031 DBMET02762 | DBMET02762 | |
| 0.015 | 0.542 | 0.114 | Ribosomal protein S6 kinase inhibitor | 0.114 0.098 DBMET02759 | DBMET02759 | |
| 0.025 | 0.591 | 0.546 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.546 0.006 DBMET02759 | DBMET02759 | |
| 0.033 | 0.601 | 0.352 | Angiogenesis inhibitor | 0.352 0.07 DBMET02768 0.297 0.094 DBMET02765 | DBMET02768 | |
| 0.076 | 0.645 | 0.249 | Peptidyltransferase inhibitor | 0.228 0.069 DBMET02759 0.249 0.052 DBMET02762 0.213 0.084 DBMET02765 0.179 0.13 DBMET02767 | DBMET02762 | |
| 0.019 | 0.598 | 0.899 | ErbB-3 antagonist | 0.565 0.002 DBMET02769 0.899 0.001 DBMET02767 | DBMET02767 | |
| 0.037 | 0.624 | 0.19 | NOS3 expression enhancer | 0.136 0.089 DBMET02768 0.19 0.045 DBMET02770 0.15 0.072 DBMET02769 | DBMET02770 | |
| 0.006 | 0.595 | 0.224 | Protein kinase A inhibitor | 0.224 0.011 DBMET02759 | DBMET02759 | |
| 0.002 | 0.601 | 0.064 | Calcium-dependent phospholipase A2 inhibitor | 0.064 0.003 DBMET02761 | DBMET02761 | |
| 0.009 | 0.621 | 0.109 | Thrombin inhibitor | 0.109 0.021 DBMET02765 0.085 0.037 DBMET02767 | DBMET02765 | |
| 0.021 | 0.636 | 0.207 | Interleukin 1 antagonist | 0.207 0.03 DBMET02761 | DBMET02761 | |
| 0.008 | 0.629 | 0.139 | Protein kinase C delta inhibitor | 0.139 0.027 DBMET02759 | DBMET02759 | |
| 0.007 | 0.629 | 0.356 | Neuraminidase (influenza) inhibitor | 0.356 0.002 DBMET02769 0.084 0.023 DBMET02765 0.253 0.004 DBMET02767 | DBMET02769 | |
| 0.015 | 0.646 | 0.219 | Falcipain 2 inhibitor | 0.13 0.037 DBMET02761 0.219 0.01 DBMET02762 | DBMET02762 | |
| 0.005 | 0.643 | 0.015 | Antibiotic Tetracycline-like | 0.015 0.012 DBMET02762 | DBMET02762 | |
| 0.014 | 0.653 | 0.221 | Falcipain inhibitor | 0.136 0.037 DBMET02761 0.221 0.011 DBMET02762 | DBMET02762 | |
| 0.005 | 0.647 | 0.278 | Melatonin 1 agonist | 0.278 0.003 DBMET02762 | DBMET02762 | |
| 0.009 | 0.654 | 0.053 | Cholecystokinin B agonist | 0.035 0.03 DBMET02768 0.038 0.026 DBMET02769 0.053 0.014 DBMET02765 0.041 0.022 DBMET02767 | DBMET02765 | |
| 0.007 | 0.659 | 0.045 | Erythropoietin receptor agonist | 0.045 0.024 DBMET02770 | DBMET02770 | |
| 0.004 | 0.66 | 0.118 | Histone deacetylase 2 inhibitor | 0.118 0.009 DBMET02761 | DBMET02761 | |
| 0.033 | 0.707 | 0.176 | Sigma receptor agonist | 0.176 0.071 DBMET02770 0.131 0.101 DBMET02765 | DBMET02770 | |
| 0.014 | 0.692 | 0.079 | Vanilloid 2 antagonist | 0.079 0.009 DBMET02759 0.071 0.014 DBMET02760 0.06 0.023 DBMET02762 | DBMET02759 | |
| 0.009 | 0.702 | 0.534 | Protein kinase C nu inhibitor | 0.534 0.005 DBMET02759 0.306 0.023 DBMET02762 0.388 0.011 DBMET02765 0.206 0.045 DBMET02767 | DBMET02759 | |
| 0.004 | 0.704 | 0.371 | Neuraminidase inhibitor | 0.371 0.001 DBMET02769 0.064 0.039 DBMET02765 0.211 0.004 DBMET02767 | DBMET02769 | |
| 0.004 | 0.704 | 0.216 | Melatonin agonist | 0.216 0.004 DBMET02762 | DBMET02762 | |
| 0.002 | 0.739 | 0.066 | KiSS-1 receptor antagonist | 0.066 0.003 DBMET02761 | DBMET02761 | |
| 0.004 | 0.742 | 0.103 | Histone deacetylase 4 inhibitor | 0.103 0.005 DBMET02761 | DBMET02761 | |
| 0.071 | 0.81 | 0.435 | Calcium channel L-type activator | 0.435 0.059 DBMET02770 0.266 0.188 DBMET02761 0.414 0.072 DBMET02762 0.266 0.188 DBMET02765 | DBMET02770 | |
| 0.005 | 0.76 | 0.379 | Elastase inhibitor | 0.379 0.003 DBMET02761 | DBMET02761 | |
| 0.015 | 0.777 | 0.056 | Cathepsin E inhibitor | 0.056 0.046 DBMET02762 | DBMET02762 | |
| 0.034 | 0.797 | 0.247 | Sodium/bile acid cotransporter inhibitor | 0.234 0.146 DBMET02769 0.247 0.131 DBMET02765 0.207 0.179 DBMET02767 | DBMET02765 | |
| 0.015 | 0.779 | 0.151 | Nav1.4 sodium channel blocker | 0.151 0.033 DBMET02770 0.131 0.044 DBMET02765 0.099 0.077 DBMET02767 | DBMET02770 | |
| 0.015 | 0.78 | 0.073 | Kallikrein 7 inhibitor | 0.073 0.022 DBMET02770 | DBMET02770 | |
| 0.017 | 0.786 | 0.095 | DNA polymerase I inhibitor | 0.095 0.091 DBMET02761 | DBMET02761 | |
| 0.003 | 0.788 | 0.057 | Melatonin 1 antagonist | 0.057 0.005 DBMET02762 | DBMET02762 | |
| 0.003 | 0.789 | 0.176 | Histone deacetylase 10 inhibitor | 0.176 0.004 DBMET02761 | DBMET02761 | |
| 0.003 | 0.79 | 0.08 | Melatonin antagonist | 0.08 0.005 DBMET02762 | DBMET02762 | |
| 0.003 | 0.793 | 0.109 | Antineoplastic antibiotic | 0.109 0.042 DBMET02769 0.068 0.066 DBMET02761 | DBMET02769 | |
| 0.004 | 0.815 | 0.052 | Cathepsin L2 inhibitor | 0.052 0.021 DBMET02761 | DBMET02761 | |
| 0.003 | 0.822 | 0.087 | Histone deacetylase 5 inhibitor | 0.087 0.011 DBMET02761 | DBMET02761 | |
| 0.003 | 0.822 | 0.033 | Corticotropin releasing factor 1 receptor antagonist | 0.033 0.009 DBMET02761 | DBMET02761 | |
| 0.004 | 0.825 | 0.062 | Baculoviral IAP repeat-containing protein inhibitor | 0.062 0.005 DBMET02762 | DBMET02762 | |
| 0.003 | 0.829 | 0.06 | Histone deacetylase class IIa inhibitor | 0.06 0.012 DBMET02761 | DBMET02761 | |
| 0.005 | 0.835 | 0.212 | Hypolipemic | 0.212 0.086 DBMET02767 | DBMET02767 | |
| 0.001 | 0.837 | 0.624 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | 0.624 0.002 DBMET02765 | DBMET02765 | |
| 0.024 | 0.861 | 0.42 | Apoptosis antagonist | 0.42 0.033 DBMET02761 | DBMET02761 | |
| 0.023 | 0.865 | 0.175 | Growth factor agonist | 0.175 0.094 DBMET02761 | DBMET02761 | |
| 0.008 | 0.853 | 0.176 | Carnitine palmitoyltransferase 1B inhibitor | 0.176 0.003 DBMET02767 | DBMET02767 | |
| 0.009 | 0.858 | 0.24 | Angiogenesis stimulant | 0.24 0.074 DBMET02765 0.145 0.126 DBMET02767 | DBMET02765 | |
| 0.006 | 0.857 | 0.033 | Antibiotic Aminoglycoside-like | 0.033 0.03 DBMET02762 | DBMET02762 | |
| 0.003 | 0.857 | 0.087 | Histone deacetylase 3 inhibitor | 0.087 0.008 DBMET02761 | DBMET02761 | |
| 0.002 | 0.863 | 0.039 | Calpain 1 inhibitor | 0.039 0.012 DBMET02761 | DBMET02761 | |
| 0.003 | 0.868 | 0.03 | Histone deacetylase class II inhibitor | 0.03 0.018 DBMET02761 | DBMET02761 | |
| 0.003 | 0.869 | 0.035 | Histone deacetylase class IIb inhibitor | 0.035 0.014 DBMET02761 | DBMET02761 | |
| 0.003 | 0.87 | 0.035 | Histone deacetylase 6 inhibitor | 0.035 0.014 DBMET02761 | DBMET02761 | |
| 0.009 | 0.88 | 0.065 | Sodium/calcium exchanger inhibitor | 0.065 0.015 DBMET02765 0.046 0.045 DBMET02767 | DBMET02765 | |
| 0.004 | 0.882 | 0.181 | HIV-1 integrase (Strand Transfer) inhibitor | 0.095 0.025 DBMET02759 0.181 0.01 DBMET02760 0.09 0.027 DBMET02761 | DBMET02760 | |
| 0.004 | 0.882 | 0.145 | HIV-1 integrase (3'-Processing) inhibitor | 0.097 0.027 DBMET02759 0.145 0.014 DBMET02760 | DBMET02760 | |
| 0.004 | 0.886 | 0.032 | Follicle-stimulating hormone antagonist | 0.032 0.005 DBMET02765 0.022 0.009 DBMET02767 | DBMET02765 | |
| 0.003 | 0.892 | 0.071 | Carnitine palmitoyltransferase 1A inhibitor | 0.071 0.004 DBMET02767 | DBMET02767 | |
| 0.004 | 0.9 | 0.068 | Cathepsin B inhibitor | 0.068 0.03 DBMET02761 | DBMET02761 | |
| 0.003 | 0.9 | 0.135 | Histone deacetylase 11 inhibitor | 0.135 0.005 DBMET02761 | DBMET02761 | |
| 0.003 | 0.9 | 0.135 | Histone deacetylase class IV inhibitor | 0.135 0.005 DBMET02761 | DBMET02761 | |
| 0.005 | 0.92 | 0.224 | Vasodilator | 0.19 0.113 DBMET02761 0.224 0.087 DBMET02765 | DBMET02765 | |
| 0.004 | 0.92 | 0.192 | Neurotrophic factor | 0.192 0.031 DBMET02761 | DBMET02761 | |
| 0.01 | 0.927 | 0.295 | Electron transport complex I inhibitor | 0.295 0.005 DBMET02761 | DBMET02761 | |
| 0.007 | 0.927 | 0.668 | Antiinflammatory | 0.668 0.037 DBMET02761 | DBMET02761 | |
| 0.008 | 0.93 | 0.148 | Farnesoid X receptor antagonist | 0.148 0.054 DBMET02761 | DBMET02761 | |
| 0.003 | 0.928 | 0.042 | Factor VIIa inhibitor | 0.042 0.024 DBMET02765 | DBMET02765 | |
| 0.005 | 0.932 | 0.293 | Cyclophilin D inhibitor | 0.293 0.169 DBMET02769 | DBMET02769 | |
| 0.003 | 0.94 | 0.283 | Glutamate (mGluR) agonist | 0.283 0.005 DBMET02767 | DBMET02767 | |
| 0.005 | 0.943 | 0.279 | Antiobesity | 0.279 0.132 DBMET02769 0.271 0.138 DBMET02767 | DBMET02769 | |
| 0.012 | 0.951 | 0.094 | 3C-Like protease (SARS coronavirus) inhibitor | 0.094 0.04 DBMET02761 | DBMET02761 | |
| 0 | 0.954 | 0.008 | Mannitol 2-dehydrogenase inhibitor | 0.008 0.005 DBMET02761 | DBMET02761 | |
| 0.004 | 0.961 | 0.099 | Transcription factor AP-1 inhibitor | 0.099 0.013 DBMET02761 | DBMET02761 | |
| 0.002 | 0.961 | 0.056 | 1,3-Beta-glucan synthase inhibitor | 0.056 0.002 DBMET02760 | DBMET02760 | |
| 0.002 | 0.965 | 0.031 | Trypsin II inhibitor | 0.031 0.02 DBMET02765 | DBMET02765 | |
| 0.007 | 0.976 | 0.153 | Factor IXa inhibitor | 0.153 0.004 DBMET02765 0.125 0.005 DBMET02767 | DBMET02765 | |
| 0.015 | 0.986 | 0.105 | Factor V inhibitor | 0.105 0.059 DBMET02765 0.094 0.086 DBMET02767 | DBMET02765 | |
| 0.01 | 0.982 | 0.453 | Caspase 3 stimulant | 0.453 0.029 DBMET02761 | DBMET02761 | |
| 0.005 | 0.977 | 0.072 | Glucose-6-phosphate translocase inhibitor | 0.072 0.015 DBMET02761 | DBMET02761 | |
| 0.005 | 0.979 | 0.055 | Factor III inhibitor | 0.055 0.023 DBMET02761 | DBMET02761 | |
| 0.004 | 0.978 | 0.21 | Nitric oxide antagonist | 0.21 0.064 DBMET02761 | DBMET02761 | |
| 0.005 | 0.98 | 0.188 | Interleukin 1b antagonist | 0.188 0.022 DBMET02761 | DBMET02761 | |
| 0.011 | 0.989 | 0.103 | Transcription factor NF kappa B stimulant | 0.103 0.036 DBMET02761 | DBMET02761 | |
| 0.002 | 0.982 | 0.042 | Trypsin I inhibitor | 0.042 0.016 DBMET02765 | DBMET02765 | |
| 0.002 | 0.983 | 0.108 | Urokinase inhibitor | 0.108 0.015 DBMET02765 0.067 0.025 DBMET02767 | DBMET02765 | |
| 0.002 | 0.984 | 0.026 | Adenosine A1 receptor agonist | 0.026 0.015 DBMET02759 | DBMET02759 | |
| 0.003 | 0.985 | 0.056 | Neuraminidase (Influenza A) inhibitor | 0.056 0.016 DBMET02765 | DBMET02765 | |
| 0.009 | 0.992 | 0.069 | Lipocortins synthesis agonist | 0.069 0.023 DBMET02761 | DBMET02761 | |
| 0.001 | 0.985 | 0.155 | Squalene synthetase inhibitor | 0.053 0.013 DBMET02769 0.029 0.025 DBMET02761 0.155 0.003 DBMET02767 | DBMET02767 | |
| 0.002 | 0.988 | 0.037 | Caspase 6 inhibitor | 0.037 0.01 DBMET02761 | DBMET02761 | |
| 0.003 | 0.991 | 0.1 | Protease inhibitor | 0.1 0.066 DBMET02761 | DBMET02761 | |
| 0.003 | 0.991 | 0.113 | Trypsin inhibitor | 0.113 0.013 DBMET02765 0.089 0.022 DBMET02767 | DBMET02765 | |
| 0.004 | 0.995 | 0.342 | Platelet adhesion inhibitor | 0.342 0.021 DBMET02761 | DBMET02761 | |
| 0.004 | 0.995 | 0.763 | Chymotrypsin inhibitor | 0.09 0.043 DBMET02760 0.763 0.001 DBMET02761 | DBMET02761 | |
| 0.004 | 0.995 | 0.035 | HCV polyprotein inhibitor | 0.035 0.02 DBMET02761 | DBMET02761 | |
| 0.003 | 0.995 | 0.065 | Elastase 1 inhibitor | 0.065 0.053 DBMET02761 | DBMET02761 | |
| 0.003 | 0.994 | 0.081 | Plasminogen activator inhibitor | 0.081 0.025 DBMET02760 | DBMET02760 | |
| 0.002 | 0.995 | 0.032 | Catechol O-methyltransferase inhibitor | 0.032 0.025 DBMET02761 | DBMET02761 | |
| 0.002 | 0.995 | 0.078 | Plasmin inhibitor | 0.065 0.026 DBMET02760 0.078 0.022 DBMET02765 0.047 0.033 DBMET02767 | DBMET02765 | |
| 0.003 | 0.996 | 0.067 | Calcium-independent phospholipase A2 inhibitor | 0.067 0.002 DBMET02761 | DBMET02761 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |